A System Dynamics Approach for the Development of a Patient-Specific Protocol for Radioiodine Treatment of Graves\u27 Disease by Merrill, Steven J
University of Massachusetts Amherst
ScholarWorks@UMass Amherst
Masters Theses 1911 - February 2014
2009
A System Dynamics Approach for the
Development of a Patient-Specific Protocol for
Radioiodine Treatment of Graves' Disease
Steven J. Merrill
University of Massachusetts Amherst
Follow this and additional works at: https://scholarworks.umass.edu/theses
This thesis is brought to you for free and open access by ScholarWorks@UMass Amherst. It has been accepted for inclusion in Masters Theses 1911 -
February 2014 by an authorized administrator of ScholarWorks@UMass Amherst. For more information, please contact
scholarworks@library.umass.edu.
Merrill, Steven J., "A System Dynamics Approach for the Development of a Patient-Specific Protocol for Radioiodine Treatment of
Graves' Disease" (2009). Masters Theses 1911 - February 2014. 260.
Retrieved from https://scholarworks.umass.edu/theses/260
A SYSTEM DYNAMICS APPROACH FOR THE
DEVELOPMENT OF A PATIENT-SPECIFIC PROTOCOL FOR
RADIOIODINE TREATMENT OF GRAVES’ DISEASE
A Thesis Presented
by
STEVEN J. MERRILL
Submitted to the Graduate School of the
University of Massachusetts Amherst in partial fulfillment
of the requirements for the degree of
MASTER OF SCIENCE IN MECHANICAL ENGINEERING
May 2009
Mechanical and Industrial Engineering
c© Copyright by Steven J. Merrill 2009
All Rights Reserved
A SYSTEM DYNAMICS APPROACH FOR THE
DEVELOPMENT OF A PATIENT-SPECIFIC PROTOCOL FOR
RADIOIODINE TREATMENT OF GRAVES’ DISEASE
A Thesis Presented
by
STEVEN J. MERRILL
Approved as to style and content by:
Yossi Chait, Co-chair
Christopher V. Hollot, Co-chair
Stuart R. Chipkin, Member
Joseph Horowitz, Member
Kourosh Danai, Member
Antonio C. Traino, Member
Mario A. Rotea, Department Chair
Mechanical and Industrial Engineering
To my family and friends.
ACKNOWLEDGMENTS
I would like to thank my advisor Professor Yossi Chait, who has provided me the oppor-
tunity to perform research in the exciting field of systems biology. His enthusiasm, patience,
and guidance have made the last two years both rewarding and enjoyable. I would also like
to thank my co-advisor Professor Christopher V. Hollot for his input into the research as well
as for his course on feedback control. As well as my co-advisor Professor Stuart R. Chipkin
for his input into the clinical aspects of the research.
I would like to extent my gratitude to Professor Joseph Horowitz for the time and effort
he has contributed to the uncertainty analysis portion of this research. I would also like to
thank Dr. Antonio C. Traino for providing the clinical data we needed to make this research
possible. As well as providing insight into the field of medical physics.
I would also like to thank Professor Kourosh Danai for serving on my thesis committee,
Rajiv P. Shrestha for his friendship and help in and out of the lab, as well my family and
friends for their support.
v
ABSTRACT
A SYSTEM DYNAMICS APPROACH FOR THE
DEVELOPMENT OF A PATIENT-SPECIFIC PROTOCOL FOR
RADIOIODINE TREATMENT OF GRAVES’ DISEASE
MAY 2009
STEVEN J. MERRILL
B.S., UNIVERSITY OF MASSACHUSETTS AMHERST
M.S.M.E., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Yossi Chait and Professor Christopher V. Hollot
The thyroid gland secretes hormones that help to govern metabolism and energy ex-
penditure within the body [1]; these hormones also affect growth and development. As a
result, the regulation of thyroid hormones is vital for maintaining an individual’s well being.
Graves’ disease is an autoimmune disorder and is a major cause of hyperthyroidism or an
overproduction of thyroid hormones. Radioactive iodine (RAI) therapy has become the pre-
ferred treatment with typical RAI protocols being based on the Marinelli-Quimby equation
to compute the dose; however, up to 90% of subjects become hypothyroid within the first
year after therapy. In this thesis we focus on the development of a new computational proto-
col for the calculation of RAI in the treatment of Graves’ hyperthyroidism. The new protocol
implements a two-compartment model to describe RAI kinetics in the body, which accounts
for the conversion between different RAI isotopes used in diagnostic and therapeutic appli-
vi
cations. Thus, by using the measured response of the subject’s thyroid to a test dose of 123I,
the model predicts what amount of RAI (131I) will be needed to reduce, through ablation,
the functional, thyroid volume/mass to an amount that would result in a normal metabolic
balance. A detailed uncertainty analysis was performed using both a standard propagation
of error method as well as a simulation method. The simulation method consisted of both
parametric and nonparametric bootstrapping techniques. Using clinical data consisting of
activity kinetics and mass dynamics of 17 subjects and measured final mass values of 7 of
the 17 subjects, we were able to validate the protocol as well as quantify the uncertainty
analysis. This protocol is the basis of an ongoing pilot study in conjunction with Cooley
Dickinson hospital, Northampton, MA.
vii
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CHAPTER 1
INTRODUCTION
The thyroid gland secretes hormones that help regulate metabolism and energy expen-
diture within the body [1]; these hormones also affect growth and development. As a result,
the regulation of thyroid hormones is vital for maintaining an individual’s well being. One
form of thyroid dysfunction, which affects the secretion of hormones, is hyperthyroidism.
Hyperthyroidism occurs when there is an overproduction of thyroid hormones due to a vari-
ety of reasons. It can lead to mild/moderate health risks, including nervousness, weight loss,
sweating, tachycardia, and fatigue [1, 2, 3]. If left untreated, these symptoms can progress
to more severe symptoms. For example, nervousness can progress into mental status changes
and tachycardia can progress into arrhythmia.
When this overproduction of hormones is caused by thyroid stimulating anti-bodies,
produced by the autoimmune system, it is known as Graves’ Disease. Graves’ disease is the
most common form of hyperthyroidism and is more common in women than men [1, 2, 3].
Graves’ disease occurs in 1-2 % of Americans and is approximately eight times more frequent
in women than men [3]. As a result of the severity of the health risks mentioned above, a
safe and effective treatment for Graves’ disease is required. Currently, the three main forms
of treatment are surgery, medication, and radioactive iodine (RAI) therapy [1, 2, 3]:
1. Surgery. The surgical treatment option usually involves subtotal thyroidectomy or
the removal of most of the thyroid. While surgery is one of the oldest forms of therapy
for hyperthyroidism caused by Graves’ disease it is rarely used today [3]. Along with
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complicati ons that accompany any surgery such as bleeding and infection, there can
also be damage to the recurrent laryngeal nerve [3]. There is also debate on how
much thyroid tissue to remove [1]. If not enough tissue is removed there is a chance of
recurrent hyperthyroidism and if too much tissue is removed hypothyroidism (under
active thyroid gland) will result. Therefore, surgery is usually performed on a limited
number of cases involving children, pregnant women, and subjects with large goiters
[3].
2. Medication. The two main antithyroid medications are methimazole, MMI, and
propylthiouracil, PTU. The main action of MMI and PTU is to reduce thyroid hormone
production by inhibiting iodine oxidization in the thyroid [1, 3]. PTU has the added
effect of inhibiting conversion of the thyroid hormone Thyroxine, T4, to the more potent
thyroid hormone Triiodothyronine, T3, in peripheral tissue [3]. Antithyroid drugs are
usually associated with long-term treatment of Graves’ hyperthyroidism with subjects
being on antithyroid medication for 1-2 years [3]. It is reported in [1] that spontaneous
remission is seen in only 20-40 % of subjects treated with antithyroid drugs. Along
with the low remission rate, numerous side effects have been reported including fever,
rash, and agranulocytosis or a reduction in the number of white blood cells [3]. If
a patient is not euthyroid after 1-2 years, an alternative treatment is usually given
because of the ongoing risk and seriousness of the side effects.
3. Radioactive Iodine. Radioactive iodine therapy has been administered to treat
Graves’ hyperthyroidism for over 50 years [4]. It is reported in [5] that RAI has become
the primary treatment used by clinicians for the treatment of Graves’ hyperthyroidism
in the United States. RAI is administered orally in capsule form and is quickly con-
centrated in the thyroid. 131I, the most common radioiodine isotope used in therapy,
emits both beta and gamma radiation. However, it is only the beta radiation that
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causes thyroid cell destruction [3]. The idea is that the thyroid will produce less hor-
mones with fewer cells. Cell destruction is often referred to as mass destruction. RAI
is relatively safe as side effects are uncommon with the exception of hypothyroidism
[6]. Up to 90 % of subjects become hypothyroid within the first year after RAI therapy
and about 2 % to 3 % become hypothyroid each year following the first [3].
In this thesis, we focus on RAI therapy. Currently, there is an ongoing debate on how much
RAI activity needs to be administered. The three main protocols are to: 1) administer a
fixed dose of RAI activity to all subjects, 2) administer a dose of RAI activity that was
calculated using an absorbed dose that was fixed for all subject (i.e. the activity absorbed
per unit mass in the target region), and 3) administer a dose of RAI activity based on an
absorbed dose that has been calculated on a subject to subject basis. This debate will be
discussed in detail in Chapter 2. We will follow the third protocol in this thesis. We will
attempt to add rigor into the protocol by explicitly considering the underlying dynamics
governed by the physics of radiation therapy.
1.1 Clinical Data
In order to test our protocol, we required clinical activity and mass data. Dr. Traino
was generous enough to supply us with both clinical activity and mass data for 17 subjects;
including mass values measured at one year for 7 of the 17 subjects. This data allowed us
to both validate our new protocol and to quantify the uncertainty analysis. All of the data
can be found in Appendix A.
1.2 Thesis Contributions
The contributions of this thesis are:
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1. We present a new computational protocol for the calculation of RAI in the treatment of
Graves’ hyperthyroidism. This protocol was developed by utilizing a two-compartment
model to describe the activity kinetics in the body and an improved method of estimat-
ing the mass dynamics required to calculate the absorbed dose. The activity kinetic
model allows for the conversion between different RAI isotopes, which is a crucial step
in our protocol.
2. A detailed uncertainty analysis was performed of the new protocol. The uncertainty
analysis consisted of both a standard propagation of error method and a simulation
based method. The ultimate goal of the uncertainty analysis was to estimate the
uncertainty in the calculation of the final thyroid mass. The uncertainty analysis was
also used to validate our new protocol. To our knowledge, this uncertainty analysis is
the first of its kind.
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CHAPTER 2
CURRENT PROTOCOLS FOR RAI DOSE COMPUTATION
Radioactive iodine has become the primary treatment for Graves’ hyperthyroidism in
the United States, however, there is not a consensus on how much RAI activity needs to be
administered or if the desired outcome is a euthyroid or hypothyroid state. The three main
protocols are to: 1) administer a fixed dose of RAI activity to all subjects, 2) administer a
dose of RAI activity that was calculated using a fixed absorbed dose for all subjects using
a version of the Marinelli-Quimby equation, and 3) administer a dose of RAI activity based
on a subject-specific absorbed dose. Each of these protocols and their limitations will be
discussed next.
2.1 Overview Of The Current Protocols
The protocol chosen by the clinician is often based on the desired outcome of the RAI
therapy, euthyroidism or hypothyroidism [4]. It has been reported in [6] that hypothyroidism
is an acceptable outcome of RAI therapy because it can be diagnosed at an early stage and
easily treated with thyroid hormone replacement. As a result, some clinicians use a large
fixed dose of RAI activity for all subjects in the hope of obtaining a hypothyroid state with
a single round of treatment [4, 7, 8, 9]. The increase in cost due to extra measurements
required for an optimized protocol also plays a role in the decision to use a fixed dose of
RAI activity [4, 7]. A variation of this protocol is to administer a fixed dose of RAI activity
per unit mass of the thyroid [4, 7]. However, these therapy protocols often result in the
administration of higher levels of activities and absorbed doses than desired. This is due
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to variability of intra-patient iodine metabolism kinetics [4, 7]. This over administration
of activity has been one of the arguments in opposition of the fixed dose of RAI activity
protocol [7].
One way clinicians try to overcome this problem is to explicitly account for the thyroid’s
iodine kinetics. This is often accomplished using empirical relations with the Marinelli-
Quimby equation being the most famous [10]. This equation accounts for the approximated
maximal iodine intake and effective half-life of iodine within the thyroid, the mass of the
thyroid, and the estimated absorbed dose. The desired quantity of absorbed dose is usually
chosen from a predetermined range based on the clinicians experience and judgment. This
approach has been reported by many clinicians, e.g., [4, 7, 11, 12, 13, 14, 15]. It provides a
patient-specific calculation of the dose of RAI activity to be administered and is preferred
over the protocol that administers a fixed dose of RAI activity to all subjects [4, 7, 13].
However, there are two limitations to this approach as well: 1) in practice, not enough
activity points are collected to accurately account for the kinetics and 2) the mass dynamics
are ignored which results in the wrong absorbed dose being used. Clinicians often manage
with only one RAI uptake measurement and assume that the maximum uptake of RAI by
the thyroid occurs at 24 hours for each subject. The second limitation is assuming the
effective half-life is 5 days for each subject. These assumptions allow for the clinician to take
only one measurement at 24 hours for each subject. Furthermore, the Marinelli-Quimby
equation assumes a fixed mass while RAI treatment always results in mass reduction. This
assumption results in a larger dose of RAI than desired. This could be the reason [3] reports
that currently up to 90 % of subjects become hypothyroid within 1 year after therapy. As
a result, most clinicians aim for a hypothyroid state after RAI therapy because a euthyroid
state is too hard to obtain.
To overcome the limitations associated with use of the Marinelli-Quimby equation, Traino
et al have proposed a model for thyroidal mass reduction after RAI therapy [16, 17, 18,
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19, 20]. The authors also report a protocol to calculate a subject specific absorbed dose.
This absorbed dose can then be used to calculate an individualized dose of RAI activity to
administer to a subject in the hopes of achieving a euthyroid state.
In this thesis, we will follow the work of Traino et al [16, 17, 18, 19, 20], however, we
will utilize a two-compartment model to describe the activity kinetics in the body and an
improved method of estimating the mass dynamics required to calculate the absorbed dose.
Before we present a description of their work, a brief discussion of mass dynamics and its
relation to the absorbed dose will be presented.
2.2 Medical Physics Background Of Radiation Effects On Cells
In [16], a new model was proposed to describe the reduction in the mass of the thyroid
after RAI therapy. A brief description of mass reduction resulting from radiation will be
discussed here in order to give some insight into the model.
In [21, 22] it has been reported that the number of cells that survive ionizing radiation
therapy, N , can be described by a linear quadratic (LQ) model
N = N0e
−(αDT+βD2T ), (2.1)
where N0 is the number of cells before therapy, DT (Gray, Gy) is the absorbed dose, and α
(Gy−1) and β (Gy−2) are constants. An important assumption is this thesis is that α and
β are the same for all subjects. Equation (2.1) describes cell death occurring due to two
types of events at the chromosomal DNA level: a single double-hit event, or double single-
hit events in the chromosomal DNA [21, 23, 24]. A single double-hit event occurs when a
single ionizing track produces a lesion in both strands in chromosomal DNA [19, 22, 25]. A
double single-hit event occurs when one ionizing track produces a lesion in one strand of the
chromosomal DNA and a separate ionizing track produces a lesion in the other strand of the
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chromosomal DNA [19, 22, 25]. In [26], these two types of events are referred to as Type A
and Type B cell destruction, respectively. In (2.1), Type A cell destruction is represented
by the term αDT , while Type B cell destruction is represented by the term βD
2
T .
In certain situations, it is possible to simplify the LQ model. The simplification results
from sub-lethal chromosomal DNA damage which is considered repairable with time [21, 25].
Sub-lethal damage can occur as a result of a few different causes. The first cause occurs
when a single ionizing track produces a lesion in one strand of the chromosomal DNA [21].
Two other cases occur when the lesions in both strands of chromosomal DNA, resulting
from either one or two tracks, are separated by greater than 3 base pairs [21]. In these
three scenarios, a second ionizing track would be required to transform them into lethal
chromosomal DNA damage. Therefore, the repair of sub-lethal damage is dependent on
the frequency of the ionizing events near the chromosomal DNA [25]. As a result, Type B
damage is also dependent on the frequency of the ionizing events because Type B damage
is associated with more than one ionizing track [25]. The frequency of the ionizing events
is directly related to the dose-rate or the rate at which the dose is absorbed by the cells
[25]. Lower dose rates provide time for sub-lethal damage to repair itself before being hit by
another ionizing track. For radiation therapy similar to RAI therapy which is administered
in high doses but at low dose rates, the βD2T term can be neglected [19, 25]. This results in
N = N0e
−αDT . (2.2)
Following the hypothesis proposed in [19] that the mass of a tissue, m, is linearly related to
N , (2.2) can be re-written to describe the ratio between the final mass m(∞) (grams, g) and
the pre-treatment mass m(0) by
m(∞)
m(0)
= e−αDT . (2.3)
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The Medical Internal Radiation Dose committee (MIRD) [27, 28] defines DT as
DT = σ
∫ ∞
0
A(t)
m(t)
dt, (2.4)
where A denotes the activity kinetics in the target tissue (Becquerel, Bq), m denotes the
mass dynamics 1 of the target tissue (grams, g), and σ is a constant dependent on the
radioisotope. Both A(t) and m(t) will be discussed in detail, in Sections 2.3.1 and 2.3.2,
respectively.
The above relations are general purpose concepts in internal radiation therapy. The mass
dynamics can be specialized to RAI therapy for a patient with Graves’ hyperthyroidism as
proposed by Traino et al [16, 18]. It is reported that thyroid mass dynamics following Type
A RAI destruction occurs in two distinct stages [18]. While [18] reports that the two stages
are distinct we believe that the two stages could be coupled. However, because of the lack
of evidence suggesting coupling we will assume that the two stages are distinct. The first
stage is assumed to occur in the first 30-35 days (0- 840 hours) after RAI administration
as a direct result of the activity of the RAI in the thyroid. The second stage is assumed to
occur between 30-35 days to 1 year (840 - 8760 hours) as a result of irreparable damage of
the thyroid cells caused by the RAI. Note that throughout this thesis we refer to these stages
in units of hours. To clarify, (2.3) describes the mass dynamics of both stages. Next, all of
the relations are specialized to RAI therapy for a patient with Graves’ hyperthyroidism as
proposed by Traino et al [16].
1This is sometimes referred to as mass destruction but, in this thesis, we will refer to cell destruction as
mass dynamics.
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2.3 Computational Protocol
The equations that relate the absorbed dose in terms of mass dynamics have been pre-
sented above in general terms. Traino et al have proposed mathematical models for both
activity kinetics and mass dynamics specific for RAI therapy [16]. These relations will be
presented next and will provide the basis for the protocol proposed in Chapter 3.
2.3.1 Activity Kinetic Model
The activity kinetics for RAI therapy for a patient with Graves’ disease can be approxi-
mated to support two distinct phases: uptake and clearance [16]. The initial uptake phase
is approximated to be linear, where the activity is 0 at the start of the application, t = 0, to
where the activity is at a maximum value, Amax, at t = Tmax (usually within 12-36 hours).
The clearance dynamics are modeled by a single exponential decay equation starting at Tmax
where A(Tmax) , Amax. The overall activity kinetics is approximated in [16] by
A(t) =
 Amax
t
Tmax
, t ∈ [0, Tmax]
Amaxe
−ρ(t−Tmax), t ≥ Tmax
(2.5)
where ρ is a patient-specific constant that depends on the physical half-life of the isotope
and on the biological half-life of the isotope in the thyroid. The physical half-life is the time
it takes the number of atoms to decay to half the original number. The biological half-life
is the time it takes the thyroid to secrete half of its RAI atoms. In this thesis, we will drop
this model of activity kinetics and use a two-compartment model to describe the activity
kinetics.
2.3.2 Mass Dynamic Model
In [16] the following mass dynamics model was proposed
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m˙(t) = −k A(t)
m(t)
, (2.6)
where k ( g
2
hrMBq
) is a patient-specific constant. Equation (2.6) describes the mass dynamics
that occur during the first stage and cannot be used to calculate the final mass m(∞) since
the destruction continues even when A(t) = 0. Based on clinical observations, [16] assumed
that m(t) = m(0), t ∈ [0, Tmax], and used
A(t) = Amaxe
−ρ(t−Tmax)
to solve (2.6) for m(t):
m(t) =
[
2
(
kAmax
ρ
e−ρ(t−Tmax) − kAmax
ρ
+
m(0)2
2
)] 1
2
. (2.7)
The subject-specific constant k can be found by fitting (2.7) to clinical mass and activity
data.
The key idea behind these relations is that, in theory, if a subjects’ activity and mass
parameters are known a priori, then one could compute the dose of RAI activity needed
to achieve a desired final mass. In practice, however, the subjects’ mass dynamics are not
known a priori. As a result, [17] has proposed a procedure to calculate the constant k
that does not require a priori knowledge of the subjects’ mass dynamics. Specifically, [17]
postulated that k is strongly correlated to key patient-specific data, m(0) and Amax, so an
estimate, referred to as kcalc, is given by
k = kcalc , γcalc
m(0)2Ad
Amax
, (2.8)
where γcalc (hr
−1MBq−1) is a fitting constant, and Ad is the initial 131I dose of activity MBq.
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2.3.3 Limitations Of The Computational Protocol That Are Addressed In This
Thesis
The method of calculating a patient-specific absorbed dose for the treatment of Graves’
hyperthyroidism, indicated above, improves on the previous protocols. However, even this
method has limitations. It is common in the USA to use 123I, a non-destructive isotope, as
a diagnostic isotope [3]. To utilize data generated from a diagnostic procedure involving a
different isotope requires a method to be able to convert 123I activity data into the therapeutic
isotope 131I activity data. The activity kinetics proposed by [16] do not allow for this
conversion. Another limitation is the absence of an uncertainty analysis reported for this
method. Traino et al [16] report an uncertainty of 10% for activity measurements and 15%-
20% for mass measurements. These values are rather large and should be propagated through
to the calculation of the absorbed dose and the final mass.
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CHAPTER 3
PROPOSED PROTOCOL FOR RAI DOSE COMPUTATION
AND ADMINISTRATION
The computational approach described in Section 2.3 is the current state-of-the-art
patient-specific approach for RAI dose calculation. We follow (2.3), however, we will re-
move the assumption of a linear uptake phase in the activity kinetics to provide a more
accurate estimate of the activity in the thyroid. A computational approach to calculate the
absorbed dose, based on new activity relations, and the approaches ability to predict the final
mass will be discussed. Also, using this computational approach, we will show that a dose
of RAI activity can be calculated to predict a desired final mass after therapy. In developing
this protocol, the following tasks were addressed: the ability to convert between different
RAI isotopes, the ability to estimate the activity parameters with a limited number of data
points, the ability to estimate the mass dynamics during the first time frame, t ∈ [0, 840],
and the ability to estimate the constant α in (2.3).
3.1 Activity Kinetic Relations
A two-compartment model to describe the flow of iodine within the body was presented
in [29]. We will adapt this model by explicitly including the physical decay constants. A
schematic diagram of our new model can be found in Figure 3.1. This model is described by
x˙1 = λux2 − λsx1 − λpx1, x1(0) = 0
x˙2 = λsx1 − λux2 − λcx2 − λpx2, x2(0) = XInput
(3.1)
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Figure 3.1. A two-compartment model of RAI flow within the body; λi represent rate
constants ( 1
hr
).
where x1 is the amount of RAI in the thyroid (µg), x2 is the amount of RAI in the plasma
(µg), λu is the rate constant associated with thyroid iodine uptake, λs is the rate constant
associated with thyroid iodine secretion, λc is the rate constant associated with urine iodine
clearance, λp is the rate constant associated with the physical decay of RAI, and XInput is
the administered dose of RAI (µg). This model assumes that the appearance of administered
RAI in the plasma is fast as can be noticed by the administration of the dose being modeled
as an impulse. The solution of (3.1) can be derived analytically and is given by the form
x1(t) = He
−bt −He−ct (3.2)
where,
H =
λuXInput
(λ2u + 2λuλc + 2λuλs − 2λcλs + λ2c + λ2s)1/2
b =
1
2
(λu + λc + 2λp + λs)− 1
2
(
λ2u + 2λuλc + 2λuλs − 2λcλs + λ2c + λ2s
) 1
2
c =
1
2
(λu + λc + 2λp + λs) +
1
2
(
λ2u + 2λuλc + 2λuλs − 2λcλs + λ2c + λ2s
) 1
2 .
Note that this model tracts the amount (µg) of RAI in the body and not the activity of RAI.
However, the amount (µg) of RAI can be converted into activity (MBq) using
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XInput =
1
δconv
1
λp
Ad,
where Ad is the dose of RAI administered (MBq), and δconv can be found using the following
conversion
MBq =
µg
hr
· nmol/hr
µg/hr
1
0.127
· moles/hr
nmol/hr
10−9 · moles/sec
moles/hr
1
3600
· disintegrations/sec
moles
6.022 · 1023 · MBq
disintegrations/sec
106
= δconv
µg
hr
= 1.317E18
µg
hr
.
Using these conversions the activity found in the thyroid can be described by
A1(t) = Y e
−bt − Y e−ct (3.3)
where,
Y =
λuAd
(λ2u + 2λuλc + 2λuλs − 2λcλs + λ2c + λ2s)1/2
b =
1
2
(λu + λc + 2λp + λs)− 1
2
(
λ2u + 2λuλc + 2λuλs − 2λcλs + λ2c + λ2s
) 1
2
c =
1
2
(λu + λc + 2λp + λs) +
1
2
(
λ2u + 2λuλc + 2λuλs − 2λcλs + λ2c + λ2s
) 1
2 .
This solution is described by two exponential terms which is notably different from Equa-
tion (2.5) which assumes a linear uptake and an exponential clearance phase. It should be
of note that the two-compartment model has only been used in one protocol to calculate a
dose of RAI activity for the treatment of Graves’ hyperthyroidism [15]. And the model used
in [15] did not explicitly account for the physical half-life of RAI.
There are a number of technical challenges related to the applicability of (3.3). One
challenge was the conversion of diagnostic activity using 123I to its corresponding therapeutic
131I activity. 123I only causes a minimal amount of mass dynamics and is therefore a desirable
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diagnostic isotope [3]. Therefore, there exists a need to estimate 131I activity dynamics from
123I activity. A second challenge was how to identify the parameters of Equation (3.3) using
a minimal number of data points. Constraints on both the subjects’ time as well as the cost
of the measurements have an effect on the number of measurements that can be taken. To
simplify the presentation, here we will assume that there is no uncertainty associated with
the activity measurements.
3.1.1 Converting Between Activities Of Different Isotopes
We can gain insight on how to convert between the different isotopes of RAI by investi-
gating the closed form solution of the activity in the thyroid. It can be observed that the
physical half-life, λp, can only be found in the two poles, b and c, in (3.3). In particular,
λp is only found in the linear portion of the two pole equations. We make the reasonable
assumption that the rate constants λu, λc, and λs will not change significantly between the
different isotopes in comparison with the dynamics of the iodine present in the thyroid. The
constant λp is known for each iodine isotope and can be assigned its value depending on the
isotope of interest. Therefore, using activity data corresponding to 123I, 131I activity data
can be estimated by switching λp of
123I for λp of
131I. An example will be shown to clarify
this procedure.
Given 123I activity data, non-linear regression of (3.3) will yield estimates of the param-
eters Yˆ , bˆ, and cˆ. The two estimates of the poles for 123I activity data can be expressed
as
bˆ123 =
1
2
(λu + λc + 2λp123 + λs)− 1
2
(
λ2u + 2λuλc + 2λuλs − 2λcλs + λ2c + λ2s
) 1
2
cˆ123 =
1
2
(λu + λc + 2λp123 + λs) +
1
2
(
λ2u + 2λuλc + 2λuλs − 2λcλs + λ2c + λ2s
) 1
2 ,
where λp123 is the rate constant associated with the physical decay of
123I. These pole esti-
mates can be converted to estimates of 131I activity data by
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bˆ131 = bˆ123 + ξ =
1
2
(λu + λc + 2λp123 + λs) + ξ − 1
2
(
λ2u + 2λuλc + 2λuλs − 2λcλs + λ2c + λ2s
) 1
2
cˆ131 = cˆ123 + ξ =
1
2
(λu + λc + 2λp123 + λs) + ξ +
1
2
(
λ2u + 2λuλc + 2λuλs − 2λcλs + λ2c + λ2s
) 1
2 ,
where ξ = λp131 − λp123. This results in estimates of the 131I poles
bˆ131 =
1
2
(λu + λc + 2λp131 + λs)− 1
2
(
λ2u + 2λuλc + 2λuλs − 2λcλs + λ2c + λ2s
) 1
2
cˆ131 =
1
2
(λu + λc + 2λp131 + λs) +
1
2
(
λ2u + 2λuλc + 2λuλs − 2λcλs + λ2c + λ2s
) 1
2 .
3.1.2 Estimating Activity Parameters With A Minimum Number Of Data Points
In an ideal case, many activity measurements would be made to aid in the identification of
the activity parameters. However, only three measurement will be made when implementing
our new protocol. The activity point A(t = 0) = 0 can be used as a fourth point. We
used clinical activity data to test whether it is possible to accurately identify the activity
parameters with a limited number of data points. Figure 3.2 shows the activity kinetics for
subject 21. The solid line represents the activity kinetics found from non-linear regression
of (3.3) and all of the measured activity data points. The dashed line represents the activity
kinetics found from non-linear regression of (3.3) and a limited number of data points. Figure
3.2 shows that even with a limited number of data points the activity parameters can still be
accurately identified. The times at which the limited number of activity points were chosen
were ti = [0, 2, 70.5, 163.6] hours. These points are representative of the times at which
the activity will be measured in our protocol. There is one measurement during the uptake
phase and two measurements taken during the clearance phase. Before deciding to estimate
the activity parameters using non-linear regression, we investigated calculating the activity
parameter analytically. This analytical approach is discussed in Appendix B.
17
Figure 3.2. Activity kinetics for subject 21. The crosses represent measured activity data
points. The solid line represents the activity kinetics fit using all measured data points. The
dashed line represents the activity kinetics fit using a limited number of data points.
3.2 Calculation Of The Absorbed Dose
In computing the absorbed dose using (2.4), we follow (2.6) as the mass dynamics model
m˙(t) = −kA(t)
m
.
This equation is only valid while there is activity present in the thyroid. We make the
assumption that A(t) ≈ 0 at t ≥ 840 from clinical data. As a result we can only directly
calculate the mass until 840 hours, m(840). Therefore, (2.6) describes the mass dynamics
occurring in the first time frame, t ∈ [0, 840]. There is no available model for m(t), t ∈
[840, 8760]. As a result we can only calculate the absorbed dose until t = 840 hours using
DT ≈ σ
∫ 840
0
A(t)
m(t)
dt,
where σ = 0.1152 Gy g
MBqhr
[16]. We investigated computing DT until other times around
840 hours, however, we found that there was negligible difference between DT values when
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calculated up to t = 720 hours or up to t = 1080 hours. These calculations can be found in
Appendix C. This integral can be computed to produce the following closed form solution
DT =
σ
k
(m(0)−m(840)) , (3.4)
where,
m(840) =
[
2
(
Y k
b
e−b 840 +
Y k
c
− Y k
c
e−c 840 − Y k
b
+
m(0)2
2
)] 1
2
. (3.5)
As stated before, if the absorbed dose can be computed for a subject a priori, then one could
compute the dose of RAI activity, Ad, that would achieve a desired final mass using (2.3) with
an estimate of α. However, before this protocol can be used, a number of technical challenges
need to be addressed. One challenge concerns the fact that a subject’s mass dynamics
during the first time frame, t ∈ [0, 840] will not be known a priori. Therefore, a method to
estimate m(840) and therefore the parameter k is required. The second challenge involves
the estimation of the constant α from (3.11). The protocol to calculate and administer Ad
will be discussed in more detail later in the chapter; however, how to estimate the mass
dynamics and α will be discussed next.
3.2.1 Estimating The Mass Dynamics During The First Time Frame, t ∈ [0,840]
As a result of a subject’s mass dynamics not being available before therapy, a method
of estimating m(840) is required to compute DT . Traino et al, [17], proposed (2.8) to
estimate the parameter k a priori. We propose a modification of this approach that utilizes
all information that will be known a priori as well as accounts for the offset from linear
regression to estimate the parameter k. Rearranging (3.5) yields
ki =
m2i (0)
gi
− m
2
i (840)
gi
, (3.6)
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where,
gi = 2Y
(
1
c
e−c 840 − 1
b
e−b 840 − 1
c
+
1
b
)
, (3.7)
and i denotes the ith subject. The initial mass, mi(0), will be measured and gi will be known
once the activity parameters are obtained, however, mi(840) will not be known a priori but
it can be estimated using two approaches: 1) by finding the average of measured m(840)
values
(
(m¯(840))2 or m2(840)
)
and 2) linear regression of
m2i (0) = kgi +m
2(840),
to provide estimates of k and m2(840). The estimate of k will not be used but the estimate
of m2(840) can be used in (3.6) as a common value for m2i (840). However, both of these
approaches to estimatem2(840) produced unreasonable results when used in (3.6) to calculate
ki. This is the result of the subject-specific nature of the mass dynamics.
To circumvent this technical limitation, we used an alternative approach. For the regres-
sion, ki in (3.6) can be replaced by what [17] refers to as kfit. kfit can be found by fitting
measured mass data to
m(t) =
[
2
(
Y k
b
e−bt +
Y k
c
− Y k
c
e−ct − Y k
b
+
m(0)2
2
)] 1
2
(3.8)
using non-linear regression. Also, we will let the term
m2i (840)
gi
, in (3.6), be defined as ϕ, and
let the linear regression estimate it. Therefore, linear regression needs to be performed on
kfiti = φ
m2i (0)
gi
− ϕ,
to estimate φ and ϕ. After performing the linear regression, the following predictive equation
for k, kpred can be obtained:
kpredi = φ
m2i (0)
gi
− ϕ. (3.9)
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Equation (3.9) differs from (2.8) in that it takes advantage of all parameters that will be
available before therapy as well accounts for the offset from the linear regression.
3.2.2 Estimating α
The constant α needs to be estimated before the dose of RAI activity can be computed.
In this thesis we follow [16, 18] and assume α is a population constant. We used clinical data
of 7 subjects to calculate α for each patient. Using measured activity data, the parameters
Y , b, and c can be identified using non-linear regression of (3.3). Then using measured mass
data, the parameter k can be identified using non-linear regression of (3.8). We decided to
use the measured mass data in calculating k instead of using (3.16) because we wanted to
take advantage of all data available to us. The absorbed dose can then be calculated using
(3.4) and the identified parameters. α can be calculated by rearranging (3.11) to yield
α =
1
DT
(ln (m(0))− ln (m(∞))) . (3.10)
Then a minimum variance estimate of α, αˆmv, can be found by using
αˆmv =
∑
αi
V (αi)∑
1
V (αi)
,
where
V (αˆi) =
0.015 + α2i (SEDT )
2
D2T
,
and where SEDT is the standard error of the absorbed dose, 0.015 corresponds to the assumed
15% multiplicative error in m(0) and m(∞), and i denotes the ith subject. This expression
was derived from the usual propagation of error formula [30, 31]. The 15% multiplicative
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error assumption will be discussed in detail in Chapter 4. The variance of αˆmv can be
calculated using
V (αˆmv) =
1∑
1
V (αi)
.
3.3 Proposed Protocol For Calculating And Administering Ad
The absorbed dose can be calculated with the estimate of m(840). However, the dose
of RAI activity, Ad, cannot be calculated without an estimate of m(∞) in (2.3). It is not
feasible to estimate m(∞), therefore, using the assumption that the second time frame of
the mass dynamics ends at 1 year, we will approximate m(∞) to be m(8760). Note that
from here on in this thesis m(∞) is defined as m(8760). Rewriting (2.3) yields
m(∞) ≈ m(0)e−αDT . (3.11)
A method to estimate m(∞) is still required. A full-order mathematical model of the thyroid
can be used to specify the desired m(∞) corresponding to a goal of becoming euthyroid [32].
The thyroid model is highly non-linear with an output of thyroid hormones in response to
an input of thyroid stimulating hormone (TSH) and iodine. The model has been shown to
match known thyroidal behavior such as the Wolff-Chaikoff block. Before the model can be
used, it needs to be parameterized for a specific subject. The model can be parameterized
using subject-specific measured values that will be known a priori, specifically, the initial
mass and the measured activity values. The mass of the thyroid is often decreased until
the thyroid hormone output of the model reaches a euthyroid state predetermined by an
endocrinologist. The mass of the thyroid that results in the euthyroid state is the desired
target m(∞).
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With estimates of m(840), m(∞), and αˆ, we will be able to calculate a dose of RAI
activity using (3.11). Equation (3.11) can be re-written as
m(∞)
m(0)
≈ e−αAdD˜T , (3.12)
where
D˜T =
DT
Ad
= σ
∫ 840
0
A˜(t)
m(t)
dt,
and where
A˜(t) =
A(t)
Ad
= Y˜
(
e−bt − e−ct) . (3.13)
Solving (3.12) for Ad yields
Ad = −
ln
(
m(∞)
m(0)
)
αD˜T
. (3.14)
The ability to calculate a dose of RAI activity that will achieve a desired final mass by
using (3.14) has lead us to develop the following 3-step protocol for administering the dose
Ad:
1. Measure the pre-therapy mass of the thyroid, m(0).
2. Administer a tracer dose of 123I. Measure the activity in the thyroid and convert the
123I data into 131I data. Compute kpred using parameters found from the
131I activity
data.
3. Compute Ad in order to achieve the desired m(∞).
3.4 Validating The Protocol
The protocol was tested by using the clinical activity and mass data presented in Ap-
pendix A. The data was used to estimate the relevant parameters required to calculate DT
and m(∞). The calculated m(∞) values were compared to the measured m(∞) values for
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each subject. As shown in Section 3.3, a normalized activity equation is required to calculate
the initial dose Ad using (3.14). Therefore, activity data, normalized by Ad, was used with
non-linear regression of (3.13) to estimate the activity parameters Y˜ , b, and c. Inserting
(3.13) into (2.6) yielded
m˙(t) = −k˘ Aˇ(t)
m(t)
,
where k˘ = Adk. Solving for m(t) yielded
m(t) =
(
2
(
Yˇ k˘
b
e−bt +
Yˇ k˘
c
− Yˇ k˘
c
e−ct − Yˇ k˘
b
+
m(0)2
2
)) 1
2
. (3.15)
k˘ was estimated by non-linear regression of (3.15) with mass data to yield k˘fit and also
calculated using (3.9) as
k˘pred = 0.5951
m(0)2
gˇ
− 0.0108, (3.16)
where, gˇ = Adg. The calculation of the constants in (3.16) can be found in Appendix D.
Only the subjects with mass values measured at one year were used to test our protocol.
The normalized activity data were used with non-linear regression to estimate the activity
parameters of (3.13) and the parameters can be found in Table 3.1. Table 3.2 reports the
mass parameter k˘fit found using non-linear regression of (3.15) using mass data.
Table 3.1. Activity parameters from (3.13) estimated using non-linear regression with
normalized activity data.
Constants # 12 # 13 # 19 # 21 # 28 # 30 # 43
Yˇ 0.909 0.772 1.232 0.820 0.517 0.988 0.466
b (hr−1) 0.0059 0.0055 0.0054 0.0071 0.0059 0.0048 0.0047
c (hr−1) 0.523 0.112 0.082 0.792 0.159 1.271 0.282
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Table 3.2. The mass parameter k˘ from (3.15) estimated using non-linear regression with
mass data.
Constants # 12 # 13 # 19 # 21 # 28 # 30 # 43
k˘fit (
g2
hr
) 1.711 2.412 0.465 1.003 0.498 0.367 0.055
Using the estimated activity and mass parameters, α was found for each subject as
described in Section 3.2.2. Table 3.3 contains α and its respective variance for each subject.
Using these values, a minimum variance estimate of α was calculated to be αˆmv=0.0031
Gy−1 with V (αˆmv)=1.30E-6 Gy−2.
Table 3.3. α and its respective variance are reported for each subject. α and its variance
were calculated as described in Section 3.2.2.
Constants # 12 # 13 # 19 # 21 # 28 # 30 # 43
α (Gy−1) 0.0036 0.0037 0.0027 0.0037 0.0032 0.0023 0.0040
V (α) (Gy−2) 1.53E-5 2.90E-5 2.75E-5 3.76E-6 2.46E-5 3.62E-6 1.98E-5
Using αˆmv for all subjects, m (∞) was calculated using (3.11). DT was calculated using
three estimates of k˘: 1) k˘fit was estimated using non-linear regression of (3.15) with mass
data 2) k˘pred was calculated using (3.16) and 3) k˘calc was calculated using (2.8). Table 3.4
contains estimates of k˘fit, DT and m (∞).
Table 3.5 reports calculations of k˘pred, DT , and m (∞). The parameter estimates are
similar between Tables 3.5 and 3.4. This provides evidence that k˘pred provides a reasonable
estimate of k˘ and can be used to accurately calculate m (∞).
Table 3.6 reports calculations of k˘calc, DT , and m (∞). The parameter values from Table
3.6 are reasonably close to the parameter values in Tables 3.4 and 3.5.
To validate the protocol we compared the calculated m(∞) values to the measured values
which are reported in Table 3.7. We minimized the error between the two m(∞) values by
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Table 3.4. Calculated values of k˘fit, DT , and m(∞). k˘ was found using non-linear regression
of (3.15).
Constants # 12 # 13 # 19 # 21 # 28 # 30 # 43
k˘fit (
g2
hr
) 1.71 2.41 0.47 1.00 0.50 0.37 0.06
DT (Gy) 427 459 728 347 367 596 379
m(∞) (g) 8.2 6.2 2.0 5.9 4.9 2.4 2.7
Table 3.5. Calculated values of k˘pred, DT , and m(∞). Each parameter’s standard error
values, found through Taylor series approximation, are reported.
Constants # 12 # 13 # 19 # 21 # 28 # 30 # 43
k˘pred (
g2
hr
) 2.00 1.64 0.62 0.84 0.90 0.37 0.24
DT (Gy) 443 380 774 327 407 596 442
m(∞) (g) 7.7 8.0 1.8 6.3 4.3 2.4 2.2
Table 3.6. Calculated values of k˘calc, DT , and m(∞). Each parameter’s standard error
values, found through Taylor series approximation, are reported.
Constants # 12 # 13 # 19 # 21 # 28 # 30 # 43
k˘calc (
g2
hr
) 1.80 1.74 0.70 0.62 0.88 0.40 0.28
DT (Gy) 431 387 804 307 404 610 467
m(∞) (g) 8.0 7.8 1.6 6.7 4.4 2.3 2.0
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taking the square root of the sum of the squares between the two values. The error between
the m(∞) values calculated using k˘pred and the measured m(∞) values was 3.96. The error
between the m(∞) values calculated using k˘calc and the measured m(∞) values was 4.12.
This implies that k˘pred provides a more accurate m(∞) than k˘calc.
Table 3.7. Mass values measured at one year.
Constants # 12 # 13 # 19 # 21 # 28 # 30 # 43
m(∞) (g) 7 5 3 5 5 4 2
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CHAPTER 4
UNCERTAINTY ANALYSIS - THEORETICAL AND
COMPUTATIONAL CONSIDERATIONS
The central challenge in computing a subject-specific RAI dose to achieve a desired
m (∞) relates to figuring out how measurement and parameter identification errors affect
the prediction accuracy of the final result. This problem can be stated as follows.
Central Prediction Problem. Let the target subject mass m (∞) be related to activity kinetics
and mass dynamics by the following relations (see Chapter 3)
m (∞) = m(0)e−αDT
DT =
σ
k
(m(0)−m(840))
A(t) = Y
(
e−bt − e−ct)
m(t) =
[
2
(
Y k
b
e−bt +
Y k
c
− Y k
c
e−ct − Y k
b
+
m(0)2
2
)] 1
2
, t ∈ [0, 840]
where all parameters in the above relations are unknown with the exception of σ. Given nA
activity measurements, A˜(ti), and nm mass measurements, m˜(ti), estimate the true expected
value of m (∞) in terms of its predicted value
m (∞) ,
and confidence interval
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[mL (∞) ,mH (∞)].
Before the predicted value, m (∞), and confidence interval, [mL (∞) ,mH (∞)], can be
obtained, the activity and mass parameters first need to be identified using non-linear regres-
sion and one should clarify which parameters are subject-specific and which can be considered
population constants. Note that in this chapter we will write m (∞) as m (∞) to simplify
the notation. In this thesis we follow [16, 18] and assume α to be a population parameter,
while all other parameters are evaluated as subject-specific values. All computations are
based on clinical data consisting of activity and mass data sets of 17 subjects and mass
values measured at one year for 7 of the 17 subjects [16].
The most common standard propagation of error used to quantify the confidence interval
involves uncertainty propagation via the square root of the sum of squares method (RSS)
[30, 31]. This method requires the standard error, SE, of each of the parameters. The
standard errors can be obtained from non-linear regression and are estimates of the true
standard error of the mean for each of the parameters. We pursued this route (see Section
4.6) but decided to discontinue due to unreasonably large standard errors in DT and m (∞).
Such large values might be due to the small sample size in the clinical data and/or a poor
accuracy of the first-order expansion in the analytical derivations. Our work, therefore,
focuses on a simulation-based study which involves the generation of additional data [33, 34].
As described in Section 2.3.3, Traino et al [16] reports the uncertainties for activity and mass
measurements as percentages or relative errors. Relative errors correspond to multiplicative
measurement errors, therefore, we assume a multiplicative measurement error model in the
activity and mass models for an individual subject
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A˜(ti) =
(
Y e−bti − Y e−cti) (1 + Ai) ,
m˜(ti) =
((
2
(
Y k
b
e−bti +
Y k
c
− Y k
c
e−cti − Y k
b
+
m(0)2
2
)) 1
2
)
(1 + mi) ,
where Ai and mi are independent random variables. The data can be simulated using two
methods:
1. Parametric bootstrapping, and
2. Nonparametric bootstrapping,
which are described next.
4.1 Parametric Bootstrapping
Parametric bootstrapping can be used for generating additional data by assuming the
measurement error associated with the data belongs to a known distribution with either
specified or unspecified parameters [33, 34]. Therefore, this method can be used to simulate
additional activity and mass data which can be used to obtain additional activity and mass
parameters. This section focuses on the assumed distributions of the measurement error and
the procedure used to simulate the additional data. Note that we assume the same error
distribution for all subjects, which may be a limitation to the validity of the results. The
results from this section can be found in Chapter 5. The additional parameters obtained
from the simulated data can be used to estimate m (∞) as described in Section 4.3. Section
4.4 describes an alternative method to simulate the mass parameter k. Section 4.5 describes
different ways to analyze the simulation results including how to estimate the confidence
interval in the estimated m (∞) values, as well as, various tests that can be performed to
determine the distribution of the measurement errors.
A method to estimate the original activity and mass parameters using non-linear re-
gression of the measured activity and mass data is required before the simulations can be
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performed and will be described next. Again, by assuming a multiplicative measurement
error, the measured activity in the thyroid is described by
A˜(ti) =
(
Y e−bti − Y e−cti) (1 + Ai) , i = 1, . . . , nA, (4.1)
where Ai are independent, identically distributed random variables. However, (4.1) is not
suitable for non-linear regression because the error term is not additive. An additive error
model is obtained by taking the natural logarithm of (4.1)
ln
(
A˜(ti)
)
= ln (Y ) + ln
(
e−bti − e−cti)+ ln (1 + Ai) , i = 1, . . . , nA. (4.2)
The new error term in (4.2) has an expected value E (ln (1 + Ai)) = µA. Since non-linear
regression requires the error term to have an expected value of zero, we re-write (4.2) as
ln
(
A˜(ti)
)
= µA + ln (Y ) + ln
(
e−bti − e−cti)+ ηAi, i = 1, . . . , nA, (4.3)
where ηAi , ln (1 + Ai) − µA. The new error term ηAi has an expected value E (ηAi) = 0
and variance V (ηAi) = σ
2
ηA
. Note that µA and Y in (4.3) cannot be estimated separately.
To circumvent this technical limitation, we can substitute a numerical value of µA into (4.3).
Expected values of µA can be calculated by assuming a specific statistical distribution and
will be described below.
Assuming a multiplicative measurement error and using the activity parameters estimated
from the measured activity data, the measured mass is described by
m˜(ti) =
(2( Yˆ k
bˆ
e−bˆti +
Yˆ k
cˆi
− Yˆ k
cˆ
e−cˆt − Yˆ k
bˆ
+
m(0)2
2
)) 1
2
 (1 + mi) ,
i = 1, . . . , nm,
(4.4)
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where mi are independent, identically distributed random variables. Following the same
arguments used above, a mass model suitable for non-linear regression is obtained
ln (m˜(ti)) = µm + ln
(2( Yˆ k
bˆ
e−bˆti +
Yˆ k
cˆ
− Yˆ k
cˆ
e−cˆti − Yˆ k
bˆ
+
m(0)2
2
)) 1
2
+ ηmi,
i = 1, . . . , nm,
(4.5)
where ηmi , ln (1 + mi) − µm. The error term ηmi has an expected value E (ηmi) = 0 and
variance V (ηmi) = σ
2
ηm .
The measurement errors are used to simulate the additional data, however, very little
is known about the statistical properties of these errors. As a result, we investigate the
statistical properties of the measurement error using two approaches:
1. The errors are uniformly distributed, and
2. The errors are normally distributed.
We chose to model the errors to follow a uniform distribution based on the fact that Dr.
Traino believes that the measurement errors are from a uniform distribution. We chose to
model the errors to follow a normal distribution because this is the usual assumption for
measurement errors. Both distributions will be discussed next. Note that we assume the
same error distribution for all subjects.
4.1.1 Uniform Error Assumptions
The activity measurement errors, Ai, are independent random errors and assumed to be
Unif(-ζ,ζ). Therefore, it follows that the term (1 + Ai) is Unif(1-ζ, 1+ζ), we chose ζ = 0.10
for activity data based on the 10% error in the activity measurements reported in [16].
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Expected values for µA and σ
2
ηA
following the uniform distribution, µAU and σ
2
ηAU
, can be
calculated as follows:
µAU = E (ln (1 + Ai)) =
1
2ζ
∫ ζ
−ζ
ln (1 + Ai) dAi = −0.00167,
and
σ2ηAU =
1
2ζ
∫ ζ
−ζ
(ln (1 + Ai)− µAU)2 dAi = 0.00334,
where the subscript U refers to the uniform distribution.
The mass measurement errors, mi, are independent random errors and assumed to be
Unif(-ζ,ζ). Therefore, it follows that the term (1 + mi) is Unif(1-ζ, 1+ζ), we chose ζ = 0.15
for mass dynamics data based on the 15% error in the mass measurements reported in [16].
Expected values for µm and σ
2
ηm following the uniform distribution, µmU and σ
2
ηmU
, can
be calculated as:
µmU = E (ln (1 + mi)) =
1
2ζ
∫ ζ
−ζ
ln (1 + mi) dmi = −0.00378,
and
σ2ηmU =
1
2ζ
∫ ζ
−ζ
(ln (1 + mi)− µmU)2 dmi = 0.0076.
4.1.2 Normal Error Assumptions
Numerical values for µA and σ
2
ηA
can be calculated by assuming the activity measurement
error, Ai, are N(0,
ζ2
9
) (ζ = 0.10). In order to get the activity measurements to fall within 3
standard deviations of the mean with a probability of 99.74%, the standard deviation, σ, is
chosen to be ζ
3
which yields a variance, σ2, of ζ
2
9
. Hence, it follows that the term (1 + Ai) will
be in the range of 1± ζ with the same probability. Expected values for µA and σ2ηA following
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the normal distribution, µAN and σ
2
ηAN
(the subscript N refers to the normal distribution),
are more difficult to calculate because
P (−∞ ≤ Ai ≤ −1) =
∫ −1
−∞
1
SD
√
2pi
e−
2Ai
2SD2 dAi = 4.9E − 198 ≈ 0,
therefore, ln (1 + Ai) is undefined with probability ≈ 0. As a result, Ai was considered to
follow a truncated normal distribution confined to the interval (-1,1):
P (Ai ≤ x| − 1 < Ai < 1) = P (Ai ≤ x
⋂−1 < Ai < 1)
P (−1 < Ai < 1) ≈ P (Ai ≤ x) ; |x| ≤ 1.
Expected values of µAN and σ
2
ηAN
can be calculated as follows:
µAN = E (ln (1 + Ai)) =
3√
2pi(ζ)
∫ 1
−1
ln (1 + Ai) e
−92Ai
2(ζ)2 dAi = −0.00056,
and
σ2ηAN =
3√
2pi(ζ)
∫ 1
−1
(ln (1 + Ai)− µAN)2 e
−92Ai
2(ζ)2 dAi = 0.00111.
Similarly, expected values for µm and σ
2
ηm can be calculated by assuming a normal sta-
tistical distribution. mi are assumed N(0,
ζ2
9
) (ζ = 0.15) to again ensure that the mass data
will fall within 3 standard deviations of the mean with a probability of 99.74%. Following
the same argument proposed above, mi are also considered to follow a truncated normal
distribution confined to the interval (-1,1). µmN and σ
2
ηmN
can be calculated as follows:
µmN = E (ln (1 + mi)) =
3√
2pi(ζ)
∫ 1
−1
ln (1 + mi) e
−92mi
2(ζ)2 dmi = −0.00125,
and
σ2ηmU =
3√
2pi(ζ)
∫ 1
−1
(ln (1 + mi)− µmN)2 e
−92mi
2(ζ)2 dmi = 0.00252.
The activity and mass data can be simulated using both of these assumed distributions
of the measurement error as will be described next. To aid in the procedure, consider that
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subject ` has n`A activity data points measured at times ti. The superscript ` denotes the
`th subject and ti ∈
{
t`A
}
where
{
t`A
}
=
{
t`1, . . . , t
`
n`A
}
. Also, subject ` has n`m mass data
points measured at times ti. The superscript ` denotes the `
th subject and ti ∈
{
t`m
}
where{
t`m
}
=
{
t`1, . . . , t
`
n`m
}
. The procedure to simulate the activity and mass data is split into
two sections for clarity.
4.1.3 Simulating Activity Kinetics
Non-linear regression of (4.3) using the measured activity data for subject ` yields esti-
mates of the original activity parameters Yˆ , bˆ, and cˆ. Using these activity parameters, N
simulated activity data sets can be created:
A˜sim(ti) = Yˆ
(
e−bˆti − e−cˆti
)
(1 + Ai) , ti ∈
{
t`A
}
,
where  = 1, . . . , N for patient `. The error terms Ai can be computed from either the
Unif(−ζ, ζ) or N(0, ζ2
9
) distributions, with ζ=0.10. Figure 4.1 demonstrates the simulation of
activity data for subject 12. At each time, ti, there are N simulated data points. Each of the
N simulated data sets can be put into the form of (4.3) and used in a non-linear regression
routine to estimate the activity parameters for that set. For example, the th set for subject
` will be
ln
(
A˜sim(ti)
)
= µA + ln (Y ) + ln
(
e−bti − e−cti)+ ηAi, ti ∈ {t`A} ,
Non-linear regression yields parameter estimates of Yˆ , bˆ, cˆ, and
(
σˆηA
)2
where  = 1, . . . , N .
These parameters can be studied using methods described in Section 4.5.
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Figure 4.1. Activity kinetics for subject 12. The crosses represent the original measured
activity data points. The circles represent the simulated activity data points. At each time,
ti, there are N simulated data points.
4.1.4 Simulating Mass Dynamics
The simulation of the mass dynamics were performed in a similar manner to the activity
simulations. Non-linear regression of (4.5) using the measured mass data for subject ` yields
estimates of the original mass parameters µˆm and kˆ. Using these mass parameters and the
N sets of activity parameters, N simulated mass data sets can be created:
m˜sim(ti) =
(2( Yˆ kˆ
bˆ
e−bˆ
ti +
Yˆ kˆ
cˆ
− Yˆ
kˆ
cˆ
e−cˆ
ti − Yˆ
kˆ
bˆ
+
(m(0))2
2
)) 1
2
 (1 + mi) ,
ti ∈
{
t`m
}
,
where  = 1, . . . , N for patient `. The error term mi can be computed from either the
Unif(-ζ, ζ) or N(0, ζ
2
9
) distribution with ζ = 0.15. The m(0) term can also be simulated for
each data set using the simulated mi` error terms as
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m(0) = m(0)
(
1 + 1m1
)
Each of the simulated data sets can be put into the form of (4.5) and used in a non-linear
regression routine to estimate the mass parameter for that set. For example, the th set
would be
ln (m˜sim(ti)) = µm + ln
(2( Yˆ 
bˆ
e−bˆ
ti +
Yˆ k
cˆ
− Yˆ
k
cˆ
e−cˆ
ti − Yˆ
k
bˆ
+
(m(0))2
2
)) 1
2
+ ηmi,
ti ∈
{
t`m
}
.
Note that Yˆ , bˆ, and cˆ are as in Section 4.1.3. Non-linear regression will yield parameter
estimates of µˆm, kˆ
, and
(
σˆηm
)
where  = 1, . . . , N . These parameters can be studied using
methods described in Section 4.5.
4.2 Nonparametric Bootstrapping
Nonparametric bootstrapping is used to study the distribution of the parameter estima-
tors without an a priori statistical distribution assumption [33, 34]. Activity and mass data
can be simulated by using the residuals obtained from regression of the measured activity
and mass data and assuming that the residuals are independent and identically distributed
[35]. An alternative form of (4.3) will be used to estimate the activity parameters because
of the need to eliminate the assumptions associated with the numerical value of µA. This
section describes how the activity and mass parameters are estimated, how the residuals
are obtained from non-linear regression, and how the additional activity and mass data are
simulated using these residuals. The results from this section can be found in Chapter 5.
The simulated data are then used to estimate m (∞) as described in Section 4.3. Section
4.4 describes an alternative method to simulate the mass parameter k. Section 4.5 describes
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different ways to analyze the simulation results including how to estimate the confidence
interval in the estimated m (∞) values, as well as, various tests that can be performed to
determine the distribution of the measurement errors.
4.2.1 Simulating The Activity Kinetics Using Residuals
As first described in Section 4.1, the expected value µA is required a priori in order to
perform non-linear regression on (4.3). However, this forces a specific statistical distribution
on Ai and as a result proper analysis can not be conducted to verify the actual distribution
of Ai. To circumvent this technical limitation, (4.3) can be re-written as
ln
(
A˜(ti)
)
= z + ln
(
e−bti − e−cti)+ ηAi, (4.6)
where z = µA + ln (Y ). Non-linear regression of (4.6) using the original measured activity
data yields predicted (or ”fitted”) values of activity given by
ln
(
Aˆ(ti)
)
= zˆ + ln
(
e−bˆti − e−cˆti
)
. (4.7)
The residuals were then calculated as the difference between the natural log of the original
measured activity data points, ln
(
A˜(ti)
)
, used in the regression and the expected activity
values calculated using (4.7). Mathematically the residuals can be written as
rAi = ln
(
A˜(ti)
)
− ln
(
Aˆ(ti)
)
.
The residuals for all subjects should be stored together yielding a bank of residuals which
can be used to simulate the activity data. Note that this approach assumes that the error
distributions are the same for all subjects.
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Again, consider that subject ` has n`A data points measured at times ti. From this activity
data set, estimates of the activity parameters zˆ, bˆ, and cˆ, are found for subject ` as described
on the previous page. With these estimated activity parameters, N simulated activity data
sets are created:
ln
(
A˜sim(ti)
)
= zˆ + ln
(
e−bˆti − e−cˆti
)
+ ηAi, ti ∈
{
t`A
}
.
The error terms ηAi are simulated using the residuals, that is the residuals rAi mimic ηAi.
The total number of residuals for all subjects was 43. However, bootstrap sampling is used
to simulate a large number of sets of residuals [36, 37]. Therefore, even though the total
number of residuals is small, bootstrap sampling can be used to simulate N sets of residuals
and give the effect of a larger data set. Bootstrap sampling is the random sampling of a
data set with replacement. A bootstrap sample of size w should be chosen for each of the
N simulations, where w is the total number of residuals in the data set for all ` subjects.
The bootstrap sampling should be repeated N times to yield N x w ηAi values η

Ai where
 = 1, . . . , N and i = 1, . . . , w. Simulations can be performed using each of the N sets of
errors. The ηAi values found in one of the N sets are to be used for all subjects. For example,
the first nA1 values are used for subject 1 and the next nA2 values are used for subject 2.
Where nA1 and nA2 are the number of measured data points for subjects 1 and 2 respectively.
Each of the simulated data sets were used in a non-linear regression routine to estimate the
activity parameters for that set. For example, the th set is
ln
(
A˜sim(ti)
)
= z + ln
(
e−bti − e−cti)+ ηAi, ti ∈ {t`A} .
Non-linear regression yields parameter estimates of zˆ, bˆ, cˆ, and
(
σˆηA
)2
where  = 1, . . . , N .
These parameters can be studied using methods described in Section 4.5.
39
4.2.2 Simulating Mass Dynamics Using Residuals
Non-linear regression of (4.5) with the measured mass data yields estimates of the original
mass parameters. The estimates of the activity parameters zˆ, bˆ, and cˆ can be found using
non-linear regression of the activity data as described in Section 4.2.1. Yˆ is required for the
estimation of the mass parameters and therefore needs to be calculated from the estimate of
zˆ. Recalling, from Section 4.2.1, that
zˆ = µˆA + ln
(
Yˆ
)
, (4.8)
an estimate of µˆA is required to calculate Yˆ . To estimate µˆA, the error term
ηAi = ln (1 + Ai)− µA
can be used. The residuals rAi are an approximation to the corresponding ηAi
rAi ≈ ln (1 + Ai)− µA
∴
erAi ≈ (1 + Ai) e−µA .
Taking the average of both sides yields
er ≈ (1 + ¯A) e−µA .
Following the assumption that E(Ai) = 0, it follows that ¯A ≈ 0. As a result,
er ≈ e−µA
∴
µA ≈ − ln (er) .
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An estimate of Yˆ to be used in the mass dynamics model can be calculated using (4.8) with
the estimate µˆA = −0.009.
The parameters µm and k can be estimated using non-linear regression of (4.5) with
measured mass data. The residuals can then be calculated as the difference between the
natural logarithm of the actual measured mass data points, ln (m˜(ti)), used in the regression
and the expected mass values calculated using (4.5). Mathematically this can be written as
rmi = ln (m˜(ti))− ln (mˆ(ti)) .
Again, the residuals for all subjects should be stored together yielding a bank of residuals
which can be used to simulate the mass data.
The simulation of the mass dynamics were performed in a similar manner to the activity
kinetics simulations. Consider that subject ` has n`m mass data points measured at times ti.
From this mass data set, estimates of the original mass parameters µˆm and kˆ, are found for
subject `. Using these mass parameters, and the N sets of activity parameters, N simulated
mass data sets can be created:
ln (m˜sim(ti)) = µˆm
+ ln
(2( Yˆ kˆ
bˆ
e−bˆ
ti +
Yˆ kˆ
cˆ
− Yˆ
kˆ
cˆ
e−cˆ
ti − Yˆ
kˆ
bˆ
+
(m(0))2
2
)) 1
2
+ ηmi,
ti ∈
{
t`A
}
.
The error terms ηmi can be simulated using the mass residuals. The residuals rmi mimic
ηmi. A bootstrap sample of size w can be chosen for each of the N simulations, where w is
the total number of residuals in the data set for all ` subjects. The bootstrap sampling can
be repeated N times to yield w x N ηmi values η

mi where  = 1, . . . , N and i = 1, . . . , w.
Simulations can be performed using each of the N sets of errors. The ηmi values found in
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one of the N sets can be used for all subjects. For example, the first nm1 values can be used
for subject 1 and the next nm2 values can be used for subject 2. Where nm1 and nm2 are the
number of measured data points for subjects 1 and 2, respectively. The m(0) term can also
be simulated for each data set using the simulated ηm error terms by
m(0) = m(0)
(
1 + 1mi
)
where mi ≈ e−ηmi+µm − 1. µm was found using the same procedure to calculate µA as
described above. The estimate of µm, µˆm, was calculated to be µˆm = −0.0019. Each of
the simulated data sets can be used in a non-linear regression routine to estimate the mass
parameter for that set. For example, the jth set will be
ln
(
m˜jsim(ti)
)
= µm + ln
(2( Yˆ jk
bˆj
e−bˆ
jti +
Yˆ jk
cˆj
− Yˆ
jk
cˆj
e−cˆ
jti − Yˆ
jk
bˆj
+
(mj(0))
2
2
)) 1
2
+ ηjmi,
ti ∈
{
t`A
}
.
Non-linear regression will yield parameter estimates of µˆjm, kˆ
j, and
(
σˆjηm
)2
j = 1, . . . , N .
These parameters can be studied using methods described in Section 4.5.
4.3 Predicting The Final Mass
Using the simulated activity and mass parameters obtained from either of the three
approaches, m (∞) can be calculated using (3.11),
m(∞) ≈ m(0)e−αDT .
The absorbed dose is expressed in the following closed form solution using (3.4)
DT =
σ
k
(m(0)−m(840)) , (4.9)
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where,
m(840) =
(
2
(
Y k
b
e−b840 +
Y k
c
− Y k
c
e−c840 − Y k
b
+
m(0)2
2
)) 1
2
.
Using (4.9), the absorbed dose can be calculated for each of the N simulated data sets for
subject `:
D˜T

sim =
σ
kˆ
m(0)−
(2( Yˆ kˆ
bˆ
e−bˆ
840 +
Yˆ kˆ
cˆ
− Yˆ
kˆ
cˆ
e−cˆ
840 − Yˆ
kˆ
bˆ
+
(m(0))2
2
)) 1
2
 ,
where  = 1, . . . , N and Yˆ , bˆ, cˆ, and kˆ were found using non-linear regression of the th
simulated data set.
An α value is calculated using (3.10),
α =
1
DT
(ln (m(0))− ln (m(∞))) .
For subject `, there are N simulated DT and m(0) values. By creating N more mi error
terms using one of the methods described in this chapter, N m(∞) values can be simulated
from
m(∞) = m(∞) (1 + mi) .
N α values can then be calculated for subject ` and an average α¯subject,
α¯subject =
N∑
1
α
N
,
as well as the standard deviation,
σα =
(
N∑
1
(α − α¯subject)2
N
) 1
2
,
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of the N α values can be calculated. This procedure can be repeated for all subjects. Using
the α¯subject values for each subject, a minimum variance estimate of α, αˆmv, can be calculated
αˆmv =
∑ α¯subject
V (α¯subject)∑
1
V (α¯subject)
,
where V (α¯subject) = (σ(α¯subject))
2. The variance of αˆmv can be calculated using
V (αˆmv) =
1∑
1
V (α¯subject)
.
Inserting αˆmv, into (3.11), the final mass can be calculated for each of the N simulated
activity data sets for subject `:
m˜sim(∞) ≈ m(0)e−αˆmvD

T
4.4 kpred
Throughout this chapter we have estimated the mass parameter k using non-linear re-
gression with mass data. However, the mass parameter k could have been estimated using
(3.9) to yield kpred. kpred could be simulated N times using the simulated activity parameters
as follows
k˜pred,sim = φ
(m(0))2(
Yˆ 
cˆ
e−cˆ840 − Yˆ 
bˆ
e−bˆ840 − Yˆ 
cˆ
+ Yˆ

bˆ
) − ϕ
where  = 1, . . . , N and Yˆ , bˆ, and cˆ were found using non-linear regression of the th
simulated activity kinetics data set. The m(0) terms were simulated as described in Section
4.2.2. These simulated kpred values could then be used to calculate DT as described in Section
4.3.
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4.5 Analysis
The simulations yield parameter estimates Yˆ , bˆ, cˆ, µˆm, kˆ
, DˆT , and mˆ
 (∞) where
 = 1, . . . , N . The average parameter values can be calculated. For example, the average
value of Yˆ will be the average of Yˆ 1, . . . , Yˆ N . The standard deviation of these parameter
estimates will be an approximation to the standard error of the estimator. The distribution
of each of the parameters can be studied with the use of a histogram and normal probability
plot. Also, the parameters estimated from the simulated data can be compared to parameters
estimated from the measured data. For example, the average value of Yˆ for patient `
estimated from the simulated data can be compared to Yˆ estimated from regression of the
measured data. Also, the standard deviation of the Yˆ estimated from the simulated data can
be compared to the standard error of Yˆ estimated from the measured data. If the simulation
results are reasonably close to the original regression results, then the simulations may not
be required.
The N simulated m(∞) values can be used to estimate its confidence interval by finding
the percentiles of the N values [38]. For example, if a 95% confidence level is desired, the
2.5% and 97.5% percentiles can be found from the N m(∞) values and the corresponding
values at these percentiles will make up the uncertainty band or confidence interval.
4.5.1 Testing The Measurement Error Distribution Assumptions
Various methods exist to informally test which assumption about the statistical distri-
butions of the activity and mass data are correct. One method is to compare the estimates
of µ (µ = µA or µm) and σ
2
η (σ
2
η = σ
2
ηA
or σ2ηm) found from the non-linear regression to their
expected values. However, this method will not apply to the activity data because a numer-
ical value of µA was inserted into (4.3). Non-linear regression of (4.5) provides estimates of
the parameters µˆm, kˆ, and σˆ
2
ηm . If µˆ and σˆ
2
η are close to their expected values for a particular
assumption, it will support that assumption. If the values are not close to the expected
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values of either the uniform or normal distribution, then an alternative error distribution
might need to be considered.
A second method is to investigate the residuals ri (ri = rAi or rmi) from the non-linear
regression of Equations (4.3) and (4.5) while assuming either a uniform or normal error
distribution. If the models were fit successfully, the residuals should mimic the ηi values
ri ≈ ηi = ln (1 + i)− µ,
where (i = Ai or mi). Therefore,
ri + µ ≈ ln (1 + i) .
Solving for i yields
i ≈ eri+µ − 1.
The i values should either be approximately Unif(-ζ,ζ) or approximately N(0,
ζ2
9
). These
assumptions can be assessed by using histograms and normal probability plots of i.
Various test can also be performed on the residuals themselves to try and gain insight
into their statistical distribution. The tests include side by side box plots, normal probability
plots, and histograms. The box plots are for each subject’s residuals separately, while the
normal probability plot and histogram are for all the residuals together. The box plots will
provide evidence of whether each subject shares the same distribution and the normal prob-
ability plot and histogram will provide evidence of which distribution the subjects possibly
share.
4.6 Standard Propagation of Error Method
The usual propagation of error formula to calculate the standard error of a variable, f ,
which is a function of variables, x and y, can be expressed as
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SEf(x,y) =
[(
∂f(x, y)
∂x
SEx
)2
+
(
∂f(x, y)
∂y
SEy
)2] 12
. (4.10)
The uncertainty of the final result can be obtained by multiplying the standard error by a
student t value [30, 31]. For example, the standard error of m (∞) will be computed using
the standard errors of m(0), α, and DT . The method consists of calculating a Taylor series
approximation about each of the parameters. The approximation of each parameter is then
multiplied by its respective standard error, SE, and all the terms are combined taking the
square root of the sum of the squares of the individual terms to provide the SE of the final
answer. An example of the standard propagation of error method will now be shown. The
final mass of the thyroid is defined as
m(∞) ≈ m(0)e−αDT .
To emphasize the dependence on the individual parameters, the above equation is re-written
as
m(∞) ≈ F (m(0), α,DT (m(0), k,m(840) (Y, b, c,m(0), k))) .
The Taylor series approximations were found by taking the partial derivatives of m(∞) with
respect to α, m(0), k, Y , b, and c. These partial derivatives were used to calculate the
variance of m(∞) as follows
SE(m(∞)) =
[(
∂m(∞)
∂α
SEα
)2
+
(
∂m(∞)
∂m(0)
SEm(0)
)2
+
(
∂m(∞)
∂k
SEk
)2
+
(
∂m(∞)
∂Y
SEY
)2
+
(
∂m(1 year)
∂b
SEb
)2
+
(
∂m(∞)
∂c
SEc
)2
+ 2
∂m(∞)
∂Y
∂m(∞)
∂b
COV (Y, b) + 2
∂m(∞)
∂Y
∂m(∞)
∂c
COV (Y, c)
+2
∂m(∞)
∂b
∂m(∞)
∂c
COV (b, c)
]1/2
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The activity parameters, standard error, and covariance terms were estimated from the non-
linear regression of the measured activity data. The uncertainty of m(∞) can be calculated
using
δm = SE (m(∞)) t,
where t is a Student’s t value.
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CHAPTER 5
UNCERTAINTY ANALYSIS RESULTS AND DISCUSSION
This chapter will present and discuss the results of the uncertainty analysis discussed
in Chapter 4. The uncertainty analysis was conducted as described in Chapter 4 with the
exception that the activity data used to estimate the activity parameters was normalized by
the initial dose, Ad. Normalized activity data was used because the activity data used in
our new protocol will be normalized as described in Section 3.4. The fact that normalized
activity data was used to estimate the activity parameters was omitted from Chapter 4 so
the theory was not cluttered with extra notation. However, repeating what was presented
in Section 3.4 to clarify the notation for this chapter, (3.3) was re-written as
Aˇ(ti) = Yˇ
(
e−bti − e−cti) , (5.1)
where Y = AdYˇ . Inserting (5.1) into (2.6) yielded
m˙(t) = −k˘ Aˇ(t)
m(t)
,
where k˘ = Adk. Solving for m(t) yielded
m(t) =
(
2
(
Yˇ k˘
b
e−bt +
Yˇ k˘
c
− Yˇ k˘
c
e−ct − Yˇ k˘
b
+
m(0)2
2
)) 1
2
. (5.2)
49
k˘ was estimated using non-linear regression to yield k˘fit and using (3.16) to yield k˘pred
k˘pred = 0.5951
m(0)2
gˇ
− 0.0108,
where, gˇ = Adg.
This chapter is organized as follows. Section 5.1 is an overview of the results for the
uncertainty analysis described in this chapter. Section 5.2 contains the results from the
parametric bootstrap simulations. The results presented in this section will be of only the
uniform distribution simulations. The normal distribution simulations resulted in confidence
intervals for m(∞) that were much to narrow to be clinically useful and therefore will only be
presented in Appendix E. Section 5.3 contains the results from the nonparametric bootstrap
simulations. Section 5.4 contains the calculation of m(∞) using parameters estimated from
data simulated from each of the methods. Finally, Section 5.5 contains the results from the
standard propagation of error method.
5.1 Summary Of The Uncertainty Analysis Results
Our goal was to see how well we can predict m(∞) and to assess the uncertainty in the
prediction. To do this we predict m(∞) in terms of its predicted value
m (∞) ,
and confidence interval
[mL (∞) ,mH (∞)].
To obtain the predicted value and the confidence interval, we used 2 methods: 1) A stan-
dard propagation of error method and 2) A bootstrap simulations method (parametric and
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nonparametric). Note that in this chapter we will write m (∞) as m (∞) to simplify the
notation.
We first looked into the standard propagation of error method. The full results from
this method can be found in Section 5.5. However, in following this method we obtained
unreasonably large SE values for DT and m(∞). Such large values might be due to the
small sample size in the clinical data and/or a poor accuracy of the first-order expansion
in the analytical derivations. The limited clinical data led us to simulate additional data.
Note that we did not return to the standard propagation of error method after starting to
investigate the bootstrap simulations.
We simulated data using the bootstrap techniques discussed in Chapter 4. When sim-
ulating data using the parametric bootstrap method, we assumed the measurement error
follows a Unif(−ζ,ζ) distribution. The full results from the parametric bootstrap method
can be found in Section 5.2. As discussed in Chapter 4, we first estimated the activity and
mass parameters using non-linear regression with the measured activity and mass data. The
residuals obtained from regression of the measured activity data were used to estimate Ai
as described in Section 4.5.1. We could not conclude if the errors follow the Unif(−ζ,ζ) or
the N(0, ζ
2
9
) distribution or neither. The same is true for mi estimated from the residuals of
the regression of the measured mass data. As a result, we simulated activity and mass data
using both distributions.
As described in Section 4.5, we compared the parameters and SE values estimated from
the simulated data to the parameters and SE values estimated from the measured data. We
can conclude that the parameters and SE values do not match well between the two methods
of estimating the parameters, with the exception of the activity parameters and SE values
estimated assuming the Unif(−ζ,ζ) distribution. This implies that while investigating the
uncertainty in m(∞), the simulated activity and mass data will be required to estimate the
activity and mass parameters. The parameters estimated from the simulated data were also
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used in histograms and normal probability plots to investigate their distributions as described
in Section 4.5. However, conclusions could not be made from these plots. It should be noted
that the parameters estimated from the data that was simulated assuming the Unif(−ζ,ζ)
distribution matched reasonably well with the parameters estimated from the data that was
simulated assuming the N(0, ζ
2
9
) distribution. However, the SE values estimated from data
simulated assuming the N(0, ζ
2
9
) distribution were on average smaller than the SE values
estimated from the data simulated assuming the Unif(−ζ,ζ) distribution. This was expected
because the variance of the Unif(−ζ,ζ) distribution is ζ2
3
, while the variance of the N(0, ζ
2
9
)
distribution is ζ
2
9
.
The absorbed dose, DT , α, and m(∞) were calculated using the parameters estimated
from the data simulated assuming the Unif(−ζ,ζ) distribution. To calculate DT , we used 3
estimates of k˘: 1) k˘fit estimated from non-linear regression, 2) k˘pred calculated using (3.16),
and 3) k˘calc calculated using (2.8). The 3 estimates of k˘ were used to investigate the various
ways to calculate DT and their effect on the prediction of m(∞). The statistical properties
of DT and m(∞) were also studied with the use of histograms. However, a conclusion of
what distribution these parameters follow could not be made from these plots alone. Here
we will present the m(∞) values calculated using activity and mass parameters estimated
from data simulated assuming the Unif(−ζ,ζ) distribution and using k˘pred to calculate DT .
The uncertainty in m(∞) will be presented in terms of the confidence interval of m(∞),
CIm(∞), as described in Section 4.5. Table 5.1 contains m(∞) values and its confidence
interval corresponding to a 95% confidence level.
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Table 5.1. m (∞) was calculated from parameters estimated from data simulated assum-
ing the uniform distribution. The confidence interval of m(∞), CIm(∞) was calculated as
described in Section 4.5 assuming a 95% confidence level. Note that this table corresponds
to Table 5.13.
Constants # 12 # 13 # 19 # 21 # 28 # 43
m (∞) (g) 8.2 8.0 1.5 6.3 4.2 2.1
CIm(∞) [5.5 11.4] [5.5 10.6] [0.8 2.4] [4.4 8.1] [2.8 5.6] [1.5 3.0]
We also simulated data using the nonparametric bootstrapping techniques discussed in
Section 4.2. Nonparametric bootstrapping is used to investigate data without assuming
the data follows a specific distribution. Therefore, we had to use a new activity equation
that does not assume a distribution as described in Section 4.2. The full results from the
nonparametric bootstrapping can be found in Section 5.3. Again, we first estimated the
activity and mass parameters using non-linear regression with the measured activity and
mass data. The residuals obtained from the regression of the measured activity and mass
data were used to simulate additional activity and mass data. We investigated these residuals
with box and whisker plots, histograms, and normal probability plots. We could not conclude
which distribution these residuals follow but we could conclude that the assumption that the
residuals for all subjects follow the same distribution is a reasonable assumption from the
box and whisker plot.
As described in Section 4.5, we compared the parameters and SE values estimated from
the simulated data to the parameters and SE values estimated from the measured data.
We can conclude that the parameters and SE values match well between the two methods
of estimating the parameters. This implies that while investigating the uncertainty in the
estimate of m(∞), the simulated activity and mass data may not be required because the
regression of the measured data provides reasonable parameter estimates. The parameters
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estimated from the simulated data were used in histograms and normal probability plots to
investigate their distributions as described in Section 4.5. However, conclusions could not
be made from these plots.
The absorbed dose, DT , α, and m(∞) were calculated using the parameters estimated
from the data simulated using the residuals. Similar to the parametric bootstrap method,
we used the 3 estimates of k˘ to calculate DT . The statistical properties of DT and m(∞)
were also studied with the use of histograms. However, a conclusion of what distribution
these parameters follow could not be made from these plots alone. The parameter estimates
of DT and m(∞) were not substantially different when calculated using either estimate of
k˘. Therefore, here we will present only the m(∞) values calculated using DT which was
calculated using k˘pred. The uncertainty in m(∞) will be presented in terms of the confidence
interval of m(∞), CIm(∞), as described in Section 4.5. Table 5.2 contains m(∞) values and
its confidence interval corresponding to a 95% confidence level. The values in Table 5.2
match very closely with the values from Table 5.1.
Table 5.2. m (∞) was calculated from parameters estimated from data simulated using
the residuals from the original regression. The confidence interval of m(∞), CIm(∞) was
calculated as described in Section 4.5 assuming a 95% confidence level. Note that this table
corresponds to Table 5.17.
Constants # 12 # 13 # 19 # 21 # 28 # 43
m (∞) (g) 8.3 7.6 1.9 7.7 4.3 1.8
CIm(∞) [5.5 11.6] [4.8 10.7] [1.1 3.1] [5.5 10.0] [2.8 6.0] [1.1 2.5]
5.2 Parametric Bootstrap Simulation Results
The results presented in this section are from the parametric bootstrap simulations.
Section 5.2.1 will present the simulation results when the uniform distribution of the error
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was assumed. This section will present both activity and mass parameters estimated from
the original regression of the measured data and from the simulated data. The parameters
obtained from the simulated data were used to calculate and investigate the error of m(∞).
The results of these calculations are presented in Section 5.4.
5.2.1 Uniform Distribution Simulation Results
To simulate the activity and mass data using the parametric bootstrap method, a dis-
tribution needs to be assumed. In this section, the distribution was assumed Unif(-ζ,ζ) as
described in Section 4.1.1. The activity parameters estimated from the measured data and
from the simulated data will be presented. Analysis of both methods will be presented along
with a comparison of both methods. The same will be repeated for the mass parameters.
5.2.1.1 Activity Results For The Uniform Distribution
The original activity parameters were estimated using non-linear regression with the
normalized measured activity data. The procedure discussed in Section 4.1 was still followed
only a normalized version of (4.3),
ln
(
˜ˇA(ti)
)
= −0.00167 + ln (Yˇ )+ ln (e−bti − e−cti)+ ηAi, (5.3)
was used for the regression of the normalized measured activity data. µA was replaced by its
expected value in (5.3) for the regression. Table 5.3 reports the original activity parameters
and their respective standard errors (SE) found using non-linear regression of (5.3) with
normalized measured activity data. Note that subject 30 does not have sufficient activity
data for non-linear regression of (5.3) and was omitted from the simulations.
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Table 5.3. The original activity parameters and their SE estimated using non-linear re-
gression of (5.3) with normalized measured activity data. A uniform error distribution was
assumed for the non-linear regression of (5.3).
Constants # 12 # 13 # 19 # 21 # 28 # 43
ln
(
Yˇ
)
0.017 -0.192 0.286 -0.169 -0.686 -0.737
SEYˇ 0.047 0.106 0.049 0.028 0.039 0.041
b (hr−1) 0.0071 0.0060 0.0052 0.0075 0.0057 0.0049
SEb 0.0002 0.0004 0.0001 0.0001 0.0002 0.0002
c (hr−1) 0.410 0.104 0.037 0.744 0.195 0.272
SEc 0.057 0.024 0.003 0.235 0.016 0.028
σ2ηA 0.064 0.004 0.089 0.001 0.009 0.004
As a result of the uniform error distribution being assumed while estimating the activity
parameters, µA and σ
2
ηA
could not be compared to their expected values in order to gain
insight of the distribution of Ai as described in Section 4.5.1. However, a histogram and
normal probability plot of Ai was used instead which was also described in Section 4.5.1.
Figure 5.1 contains a histogram and a normal probability plot of Ai for all subjects. The
purpose of these plots was to determine if Ai follows either the Unif(-ζ,ζ) or N(0,
ζ2
9
) dis-
tributions (ζ = 0.10). By inspection, the histogram suggests normality as compared with
uniformity. The normal probability plot does not provide much more information. Although
the middle of the data appears to follow a linear trend, the tails of the data depart from
linearity. However, the departure from linearity in the tails, in not uncommon for small
sample sizes. This suggests that N
(
0, ζ
2
9
)
might be reasonable for the errors and could be
used in the simulations.
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(a) Histogram of Ai for all subjects.
(b) Normal probability plot of Ai for all subjects.
Figure 5.1. Histogram and normal probability plot of Ai for all subjects assuming a uniform
error distribution. The crosses represent the Ai data points and the dotted line is used to
help evaluate the linearity of the data.
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The activity parameters were also estimated from the simulated activity data sets fol-
lowing the method described in Section 4.1.3. Section 4.5 describes how an average estimate
and standard deviation of each activity parameter can be obtained from the N = 500 sets
of simulated activity parameters. Similar to the measured data, the simulated data was also
normalized by Ad, and therefore (5.3) was used again to estimate the activity parameters.
Table 5.4 contains the estimated activity parameters and their standard deviations (SD).
The activity parameters estimated from the simulated data were used to check the ac-
curacy of the parameters estimated from the measured activity data as described in Section
4.5. The estimated activity parameter values in Table 5.4 were compared to their respective
estimated values from Table 5.3. By inspection, all parameter estimates and standard error
values match reasonably well between the two tables. For example, ln
(
Yˇ
)
= 0.019, -0.192,
and 0.290 for subjects 12, 13, and 19 respectively. These values were estimated from the
simulated data. For the same subjects, ln
(
Yˇ
)
= 0.017, -0.192, and 0.286 estimated from
the measured data. The values are identical for subject 13 and within 10% for subjects 12
and 19. The parameter estimates from the simulated data support the parameter estimates
from the measured data which suggests that the parameter estimates from the measured
data may be sufficient to investigate the uncertainty in m(∞).
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Table 5.4. Activity parameters from (5.3) and their standard deviations estimated from
the simulations which assumed a uniform distribution.
Constants # 12 # 13 # 19 # 21 # 28 # 43
ln
(
Yˇ
)
0.019 -0.192 0.290 -0.168 -0.687 -0.739
SDYˇ 0.043 0.060 0.050 0.034 0.033 0.032
b (hr−1) 0.0071 0.0060 0.0052 0.0075 0.0057 0.0049
SDb 0.0002 0.0002 0.0001 0.0001 0.0001 0.0001
c (hr−1) 0.417 0.105 0.037 0.765 0.167 0.272
SDc 0.067 0.012 0.002 0.120 0.015 0.021
σ2ηA 0.0036 0.0111 0.0036 0.0024 0.0042 0.0052
The activity parameters estimated from the simulated data can also be used to study
their distribution as described in Section 4.5. Figures 5.2(a)-5.2(c) are histograms for the
estimated activity parameters for subject 21. We have assumed that the error distribution
is the same for all subjects and therefore the results from subject 21 are representative of
all the subjects. As a result, only subject 21 will be used to provide examples for all of the
simulations. Figures 5.2(a) and 5.2(b) are histograms of ln
(
Yˇ
)
and b respectively. By in-
spection, the figures appear to possibly follow a normal distribution. However, Figure 5.2(c)
is a histogram of c and by inspection does not appear to follow a normal distribution. Fig-
ures 5.3(a)-5.3(c) are normal probability plots for each of the estimated activity parameters.
Figures 5.3(a) and 5.3(b) are normal probability plots of ln
(
Yˇ
)
and b respectively. These
figures provide more evidence that ln
(
Yˇ
)
and b may follow a normal distribution. All of the
data in Figure 5.3(a) appears to follow a linear trend, however, only the middle of the data
in Figure 5.3(b) follows a linear trend. Figure 5.3(c) is a normal probability plot of c and
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(a) Histogram of ln
(
Yˇ
)
for subject 21. (b) Histogram of b for subject 21.
(c) Histogram of c for subject 21.
Figure 5.2. Histograms of the activity parameters from (5.3) assuming a uniform error
distribution for subject 21.
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does not provide definitive evidence that c does or does not follow a normal distribution.
However, a conclusion of which statistical distribution the activity parameters follow could
not be made from these plots alone.
(a) Normal probability plot of ln
(
Yˇ
)
for subject
21.
(b) Normal probability plot of b for subject 21.
(c) Normal probability plot of c for subject 21.
Figure 5.3. Normal probability plots of the activity parameters from (5.3) assuming a
uniform error distribution for subject 21. The crosses represent the data points and the
dotted line is used to help evaluate the linearity of the data.
5.2.1.2 Mass Results For The Uniform Distribution
The original mass parameters were estimated using the method described in Section
4.1. Equation (4.5) was re-written to incorporate the normalized activity parameters which
yielded
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ln (m˜(ti)) = µm + ln
(2( ˆˇY k˘
bˆ
e−bˆti +
ˆˇY k˘
cˆ
−
ˆˇY k˘
cˆ
e−cˆti −
ˆˇY k˘
bˆ
+
m(0)2
2
)) 1
2
+ ηmi. (5.4)
Equation (5.4) was used for the initial regression of the measured mass data. Table 5.5
reports the mass parameters and their respective standard errors found using non-linear
regression of (5.4) with measured mass data. Note that the symbol ”-” was used in the table
when a parameter could not be estimated because of a lack of mass data. Specifically, data
for subjects 12 and 13 consists of two measured points. This leads to a problem of estimating
the standard errors of the mass parameters because the degrees of freedom becomes zero as
a result of the regression estimating two parameters.
Table 5.5. Mass parameters from (5.4) and their standard errors estimated using non-linear
regression with measured mass data. Note that the symbol ”-” was used in the table when
a parameter could not be estimated because of a lack of mass data.
Constants # 12 # 13 # 19 # 21 # 28 # 43
k˘fit (
g2
hr
) 1.94 2.49 0.48 1.18 0.69 0.04
SEk˘fit - - 0.04 0.07 0.09 0.06
µm 0.039 0.040 0.018 0.165 0.077 -0.015
SEµm - - 0.028 0.087 0.036 0.054
σ2ηm - - 0.0016 0.0164 0.0022 0.0043
The estimated µm and σ
2
ηm values were compared to their expected values calculated
assuming either a uniform or a normal distribution of mi as described in Section 4.5.1.
The estimated µm values from the regression are positive for all subjects with the exception
of subject 43. The estimated µm values could not support either a Unif(-ζ, ζ) or N(0,
ζ2
9
)
distribution of mi (ζ = 0.15) because both expected µm values are negative. µmU = -
0.00378 and µmN = -0.00125. This can be explained by the fact that the error model is
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correct, however there is an upward bias or that the error model is wrong. The estimated
σ2ηm values did not support either distribution. The expected σ
2
ηm values are 0.0076 and
0.0025 for the uniform and normal distribution respectively. While on the same order of
magnitude, definite support for either distribution could not be concluded.
As with the activity parameters, a histogram and normal probability plot of mi was
used to investigate the error distribution as described in Section 4.5.1. Figure 5.4 contains
a histogram and normal probability plot of mi. By inspection, the histogram of mi neither
supports the Unif(-ζ, ζ) nor the N(0, ζ
2
9
) distribution. The normal probability plot of mi
does not provide evidence that the sample does or does not follow a normal distribution. A
section of the data appears to follow a linear trend, however, the tails depart from linearity.
The mass parameters were also estimated from the simulated mass data sets following
the method described in Section 4.1.4. Section 4.5 describes how an average estimate and
standard deviation of each mass parameter can be obtained from the N = 500 sets of
simulated mass parameters. However, similar to the estimation of the mass parameters from
the measured data, (5.4) was used to incorporate the normalized activity parameters and
estimate the mass parameter from the simulated data. Table 5.6 contains the estimated
mass parameters and their standard deviations (SD).
The mass parameters estimated from the simulated data were also compared to the
mass parameters estimated from the measured mass data as described in Section 4.5. The
estimated mass parameters in Table 5.6 were compared to their respective estimated values
from Table 5.5. The mass parameter k˘fit matched reasonable well between the two tables.
For example, k˘fit = 0.49
g2
hr
and 1.18
g2
hr
for subjects 19 and 21 respectively. These values
were obtained from the simulated data. For the same subjects, k˘fit = 0.48
g2
hr
and 1.18
g2
hr
estimated from the measured data. The values match exactly for subject 21 and only
differ by 2% for subject 19. However, the standard deviations of k˘fit are on an order of
magnitude larger than the standard errors of k˘fit. For example, SEk˘fit = 0.04
g2
hr
and 0.07
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(a) Histogram of mi for all subjects.
(b) Normal probability plot of mi for all subjects.
Figure 5.4. Histogram and normal probability plot of mi for all subjects. The crosses
represent the mi data points and the dotted line is used to help evaluate the linearity of the
data.
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g2
hr
for subjects 19 and 21, while SDk˘fit = 0.16
g2
hr
and 0.24
g2
hr
for the same subjects. The
estimated µm values from the simulated data were all negative, µm = -0.0029 and -0.00003 for
subjects 19 and 21, while the µm values estimated from the measured data were all positive,
µm = 0.018 and 0.165 for subjects 19 and 21, with the exception of subject 43, µm = -0.015.
However, the standard errors of µm, SEµm = 0.028 for subject 19, and standard deviations
of µm, SEµm = 0.064 for subject 19, match well. Also, the estimated σ
2
ηm values match well
between the two tables. The fact that all of the parameters do not match well between the
two tables suggests that the simulated data are required for estimating the mass parameters
while assuming a uniform distribution of mi.
Table 5.6. Mass parameters from (5.4) and their standard deviations estimated from the
simulations which assumed a uniform distribution.
Constants # 12 # 13 # 19 # 21 # 28 # 43
k˘fit (
g2
hr
) 1.94 2.52 0.49 1.18 0.69 0.048
SDk˘fit 0.77 0.51 0.16 0.24 0.26 0.08
µm -0.0014 -0.0002 -0.0029 -0.00003 -0.0053 -0.0006
SDµm 0.0107 0.0022 0.0635 0.0673 0.0626 0.0549
σ2ηm - - 0.0075 0.0079 0.0076 0.0074
Figures 5.5(a) and 5.5(b) are histograms of k˘fit and µm, respectively. Not much can
be concluded from these plots by inspection. Another approach to gain insight into the
distributions of these parameters is to investigate the normal probability plots in Figures
5.6(a) and 5.6(b). Figures 5.6(a) and 5.6(b) are normal probability plots of k˘fit and µm
respectively. In both plots, the tails of the data deviate from linearity, which does not imply
whether these parameters follow a normal distribution or not.
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(a) Histogram of k˘fit for subject 21. (b) Histogram of µm for subject 21.
Figure 5.5. Histograms of the mass parameters from (5.4) assuming a uniform error distri-
bution for subject 21.
(a) Normal probability plot of k˘fit for subject 21. (b) Normal probability plot of µm for subject 21.
Figure 5.6. Normal probability plots of the mass parameters from (5.4) assuming a uniform
error distribution for subject 21. The crosses represent the data points and the dotted line
is used to help evaluate the linearity of the data.
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5.3 Nonparametric Bootstrap Simulation Results
The results presented in this section are from the nonparametric simulations. The simula-
tions can be performed by using the residuals from the non-linear regression of the measured
activity and mass data as the error terms. Section 5.3.1 will present how the activity resid-
uals are obtained and used to simulate the activity data. Section 5.3.2 will present how the
mass residuals are obtained and used to simulate the mass data. The parameters estimated
from the simulated data were used to calculate and investigate the error of m(∞). The
results of these calculations are presented in Section 5.4.
5.3.1 Results From Simulating The Activity Kinetics Using Residuals
The original activity parameters were estimated using non-linear regression with the nor-
malized measured activity data. The procedure discussed in Section 4.2.1 was still followed
only a normalized version of (4.6),
ln
(
˜ˇA(ti)
)
= zˇ + ln
(
e−bti − e−cti)+ ηAi, (5.5)
was used to estimate the activity parameters. zˇ = µA + ln
(
Yˇ
)
. Table 5.7 reports the
original activity parameters and their respective standard errors (SE) found using non-linear
regression of (5.5) with the normalized measured activity data.
The residuals from the regression will be used to simulate the activity data as described
in Section 4.2.1. The residuals were investigated using the usual histogram and normal prob-
ability plot as well as a box and whisker plot as described in Section 4.5.1. Figures 5.7(a)-
5.7(c) are of a histogram, a normal probability plot, and a box and whisker plot, respec-
tively, of the activity residuals rAi for all subjects. By inspection, the histogram appears
to possibly follow a normal distribution. The tails of the data depart from linearity on the
normal probability plot, which does not imply whether rAi follows a normal distribution or
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Table 5.7. The original activity parameters from (5.5) and their SE estimated using non-
linear regression with the normalized measured activity data.
Constants # 12 # 13 # 19 # 21 # 28 # 43
zˇ 0.015 -0.195 0.284 -0.171 -0.687 -0.739
SEzˇ 0.199 0.065 0.248 0.015 0.057 0.035
Yˇ 1.024 0.830 1.341 0.850 0.508 0.482
SEYˇ - - - - - -
b (hr−1) 0.0070 0.0060 0.0052 0.0075 0.0057 0.0049
SEb 0.0008 0.0002 0.0006 0.0001 0.0002 0.0001
c (hr−1) 0.411 0.104 0.037 0.745 0.165 0.272
SEc 0.271 0.013 0.012 0.050 0.024 0.022
σ2ηA 0.0641 0.0039 0.0894 0.0007 0.0092 0.0038
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not. By inspection, the box and whisker plot provides evidence that all subjects possibly
share the same statistical distribution. The median and quartile values for each subject
are within reason of each other implying that their respective distributions share the same
characteristics.
(a) Histogram of rAi for the activity data. (b) Normal probability plot of rAi for the activity
data.
(c) Box and whisker plot of rAi for the activity
data.
Figure 5.7. Analysis of the activity residuals consisted of a box and whisker plot, a normal
probability plot and a histogram.
The activity parameters were also estimated from the simulated activity data sets fol-
lowing the method described in Section 4.2.1. Section 4.5 describes how an average estimate
and standard deviation of each activity parameter can be obtained from the N = 500 sets of
simulated activity parameters. However, similar to estimating the activity parameters from
the measured data (5.5) was use to estimate the activity parameters from the simulated data.
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Note that we had to put bounds on the activity parameters while performing non-linear re-
gression on (5.5). This was due to the residuals. One of the residuals was relatively large
(rAi=0.5) and when it was added to a subjects initial activity data point it would make this
point the largest for that subject. If the initial data point is the largest value, then the data
would resemble a straight line making the estimation of the activity parameters impossible.
We used the following bounds: −3 ≤ z ≤ 1, 0 ≤ b ≤ 0.01, and 0 ≤ c ≤ 2. Table 5.8 contains
the estimated activity parameters and their standard deviations (SD).
The activity parameters estimated from the simulated data were used to check the accu-
racy of the results from the original regression of the measured activity data. The estimated
activity parameter values in Table 5.8 were compared to their respective estimated values
from Table 5.7. All parameter estimates and standard error values match reasonable well
between the two tables. For example, Yˇ = 0.920 and 0.842 for subjects 12 and 13 estimated
from the simulated data. For the same subjects, Yˇ = 1.024 and 0.830 estimated from the
measured data.
Figures 5.8(a) - 5.8(c) are histograms of zˇ, b and c respectively. By inspection, the Figures
5.8(a) and 5.8(c) do not appear to follow a normal distribution however Figure 5.8(b) does
appear to possibly follow a normal distribution.
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Table 5.8. Activity parameters from (5.5) and their standard deviations estimated from
the simulations performed using the residuals.
Constants # 12 # 13 # 19 # 21 # 28 # 43
zˇ -0.097 -0.192 -0.194 -0.169 -0.691 -0.735
SEzˇ 0.098 0.140 0.091 0.072 0.080 0.077
Yˇ 0.920 0.842 0.835 0.854 0.507 0.485
SEYˇ 0.092 0.127 0.078 0.062 0.042 0.038
b (hr−1) 0.0067 0.0060 0.0042 0.0075 0.0057 0.0049
SEb 0.0004 0.0005 0.0002 0.0003 0.0003 0.0003
c (hr−1) 0.681 0.111 0.060 0.803 0.171 0.272
SEc 0.468 0.043 0.011 0.305 0.041 0.048
σ2ηA 0.0188 0.0157 0.0172 0.0188 0.0168 0.0178
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(a) Histogram of zˇ for subject 21. (b) Histogram of b for subject 21.
(c) Histogram of c for subject 21.
Figure 5.8. Histograms of the activity parameters from (5.5) for subject 21.
Figures 5.9(a) - 5.9(c) are normal probability plots of zˇ, b, and c respectively. The figures
do not provide evidence that the activity parameters do or do not follow a normal distribution
as a result of the tails of the data departing from linearity on each plot. A conclusion could
not be made from these plots alone.
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(a) Normal probability plot of zˇ for subject 21. (b) Normal probability plot of b for subject 21.
(c) Normal probability plot of c for subject 21.
Figure 5.9. Normal probability plots of the activity parameters from (5.5) for subject 21.
The crosses represent the data points and the dotted line is used to help evaluate the linearity
of the data.
5.3.2 Results From Simulating The Mass Dynamics Using Residuals
The original mass parameters were estimated using the method described in Section 4.2.2.
Equation (5.4) was used to incorporate the normalized activity parameters and estimate the
mass parameters from the measured mass data. Table 5.9 reports the mass parameters and
their respective standard errors found using non-linear regression of (5.4) with measured
mass data.
The estimated µm and σ
2
ηm values were compared to their expected values calculated
assuming either a uniform or a normal distribution of mi as described in Section 4.5.1. The
estimated µm values from the regression are positive for all subjects with the exception of sub-
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Table 5.9. The original mass parameters from (5.4) and their SE estimated using non-linear
regression with measured mass data.
Constants # 12 # 13 # 19 # 21 # 28 # 43
k˘fit (
g2
hr
) 1.93 2.48 0.48 1.17 0.69 0.04
SEk˘fit - - 0.04 0.07 0.09 0.06
µm 0.039 0.040 0.018 0.165 0.077 -0.015
SEµm - - 0.028 0.087 0.036 0.054
σ2ηm - - 0.0016 0.0164 0.0022 0.0043
ject 43. The estimated µm values could not support either a U(-ζ, ζ) or N(0,
ζ2
9
) distribution
of mi (ζ = 0.15) because both expected µm values (µmU=-0.00378 and µmN=-0.00125 ) are
negative. The estimated σ2ηm values did not support either distribution. The expected σ
2
ηm
values are 0.0076 and 0.0025 for the uniform and normal distribution respectively. While on
the same order of magnitude, definite support for either distribution could not be concluded.
Similar to the activity residuals, the mass residuals were investigated with the use of a
histogram, normal probability plot, and a box and whisker plot as described in Section 4.5.1.
Figures 5.10(a)-5.10(c) are a histogram, a normal probability plot, and a box and whisker
plot, respectively, of the mass residuals rmi for all subjects. By inspection, a conclusion
about the distribution of the histogram cannot be made. The tails of the data depart from
linearity on the normal probability plot, which does not imply whether rmi follows a normal
distribution or not. By inspection, the box and whisker plot provides evidence that all
subjects possibly share the same statistical distribution. The median and quartile values
for each subject are within reason of each other implying that their respective distributions
share the same characteristics.
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(a) Histogram of rmi for the mass data. (b) Normal probability plot of rmi for the mass
data.
(c) Box and whisker plot of rmi for the mass data.
Figure 5.10. Analysis of the mass residuals consisted of a box and whisker plot, a normal
probability plot and a histogram.
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The mass parameters were also estimated from the simulated mass data sets following
the method described in Section 4.2.2. Section 4.5 describes how an average estimate and
standard deviation of each mass parameter can be obtained from the N = 500 sets of simu-
lated mass parameters. However, similar to the estimation of the measured mass parameters,
(5.4) was used to incorporate the normalized activity parameters and estimate the mass pa-
rameters using the simulated data. Table 5.10 contains the estimated mass parameters and
their standard deviations (SD).
The mass parameters estimated from the simulated data were also compared to the mass
parameters estimated from the measured data. The estimated mass parameters in Table 5.10
were compared to their respective estimated values from Table 5.9. All parameters except
µm match reasonable well between the two tables. For example, k˘fit = 2.16
g2
hr
and 2.60
g2
hr
for subjects 19 and 21 respectively. These values were obtained from the simulated data.
For the same subjects, k˘fit = 1.93
g2
hr
and 2.48
g2
hr
estimated from the measured data. With
the exception of subjects 28 and 43, all of the estimated µm values from the simulated data
were negative while the µm values estimated from the measured data were all positive with
the exception of subject 43. These results suggest that the simulated mass data are required
for estimating the mass parameters.
Figures 5.11(a) and 5.11(b) are histograms of k˘fit and µm, respectively. The histograms
appear to follow a normal distribution. Another approach to gain insight into the distribu-
tions of these parameters is to investigate the normal probability plots in Figures 5.12(a)
and 5.12(b). Figures 5.12(a) and 5.12(b) are normal probability plots of k˘fit and µm, re-
spectively, and do not provide evidence that the mass parameters do or do not belong to
a normal distribution because the tails of the data depart from linearity on each plot. A
conclusion could not be made from these plots alone.
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Table 5.10. Mass parameters from (5.4) and their standard deviations estimated from the
simulations performed using the residuals.
Constants # 12 # 13 # 19 # 21 # 28 # 43
k˘fit (
g2
hr
) 2.16 2.60 0.59 1.59 0.78 0.06
SEk˘fit 0.64 0.42 0.15 0.22 0.23 0.06
µm -0.0006 -0.0003 -0.0004 -0.0055 0.0009 0.0001
SEµm 0.0076 0.0036 0.0439 0.0747 0.0460 0.0448
σ2ηm - - 0.0038 0.0040 0.0042 0.0040
(a) Histogram of k˘fit for subject 21. (b) Histogram of µm for subject 21.
Figure 5.11. Histogram of the mass parameters from (5.4) for subject 21.
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(a) Normal probability plot of k˘fit for subject 21. (b) Normal probability plot of µm for subject 21.
Figure 5.12. Normal probability plots of the mass parameters from (5.4) for subject 21.
The crosses represent the data points and the dotted line is used to help evaluate the linearity
of the data.
5.4 m(∞) Calculation Results
This section presents the results of the calculation of m(∞) as described in Section
4.3. Section 5.4.1 presents the calculation of m(∞) using parameters estimated from the
uniformly distributed data. Finally, Section 5.4.2 presents the calculation of m(∞) using
parameters estimated from the nonparametric bootstrap simulations. In each section, m(∞)
will be calculated using 3 estimates of the mass parameter k˘: 1) k˘ found using non-linear
regression of mass data, k˘fit, 2) k˘ calculated using (3.16), k˘pred, and 3) k˘ calculated using
(2.8), k˘calc. The 3 estimates of k˘ are used to investigate the error in our new protocol when
using a predictive equation to calculate k˘.
5.4.1 m(∞) Calculated Using Parameters Estimated From Simulations Of The
Uniform Distribution
Using the activity and mass parameters estimated from the data simulated assuming the
Unif(-ζ,ζ) distribution, DT was calculated as described in Section 4.3. Here, k˘fit was used
to calculate DT . With an estimate of DT , α¯subject was found as also described in Section
4.3. Table 5.11 contains α¯subject and its respective variance for each subject. Using these
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values, a minimum variance estimate of α was calculated to be αˆmv=0.0033 Gy
−1. Also,
V (αˆmv)=3.35E-8 Gy
−2.
Table 5.11. For each subject an average α, α¯subject was calculated along with the variance
in α¯subject as described in Section 4.3.
Constants # 12 # 13 # 19 # 21 # 28 # 43
α¯subject (Gy
−1) 0.0038 0.0037 0.0026 0.0035 0.0031 0.0041
V (α¯subject) (Gy
−2) 1.66E-7 2.10E-7 1.06E-7 3.53E-7 2.79E-7 3.15E-7
Using αˆmv for all subjects, m (∞) could be calculated as described in Section 4.3. To
calculate m (∞), DT and thus an estimate of k˘ is required. Again, here we used k˘fit to
calculate DT and m (∞). Table 5.12 contains estimates of k˘fit, DT and m (∞). Each
parameters standard error was also found from the simulated data. The confidence interval
of m(∞), CIm(∞), was calculated as described in Section 4.5 assuming a 95% confidence
level.
The statistical distributions of DT and m (∞) were investigated with the use of his-
tograms as described in Section 4.5. Normal probability plots were not used because the
distribution of DT and m (∞) are not expected to be normal. Figure 5.13(a) is the his-
togram of DT for subject 21 and Figure 5.13(b) is the histogram of m (∞) for subject 21.
By inspection, a conclusion of the distribution of these parameters could not be made from
the histograms. The histograms are only reported for DT and m (∞) which were calculated
using k˘fit. Histograms of DT and m (∞) calculated using k˘pred and k˘calc were very similar.
Table 5.13 reports estimates of k˘pred, DT , and m (∞) which were calculated from param-
eters estimated from data that was simulated assuming the uniform distribution. Table 5.14
reports estimates of k˘calc, DT , and m (∞).
79
Table 5.12. k˘fit, DT , and m (∞) were calculated from parameters estimated from data
simulated assuming the uniform distribution. The standard deviation of the parameters
were found as described in Section 4.5. The confidence interval of m(∞), CIm(∞), was
calculated as described in Section 4.5 assuming a 95% confidence level.
Constants # 12 # 13 # 19 # 21 # 28 # 43
k˘fit (
g2
hr
) 1.92 2.53 0.49 1.19 0.69 0.05
SDk˘fit 0.76 0.51 0.15 0.23 0.26 0.08
DT (Gy) 405 454 770 372 391 370
SDDT 27.4 34.1 58.6 29.0 29.0 26.6
m (∞) (g) 8.4 6.1 1.7 5.4 4.4 2.7
SDm(∞) 1.4 1.2 0.5 0.9 0.8 0.4
CIm(∞) [6.1 11.0] [4.3 8.0] [1.0 2.6] [3.8 7.0] [3.2 5.8] [1.9 3.4]
(a) Histogram of DT for subject 21. (b) Histogram of m (∞) for subject 21.
Figure 5.13. Histograms of the DT and m (∞) for subject 21.
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Table 5.13. k˘pred, DT , and m (∞) were calculated from parameters estimated from data
simulated assuming the uniform distribution. The standard deviation of the parameters were
found as described in Section 4.5. The confidence interval of m(∞), CIm(∞) was calculated
as described in Section 4.5 assuming a 95% confidence level.
Constants # 12 # 13 # 19 # 21 # 28 # 43
k˘pred (
g2
hr
) 2.15 1.69 0.60 0.87 0.90 0.24
SD ˘kpred 0.37 0.31 0.12 0.15 0.16 0.04
DT (Gy) 417 375 805 323 414 440
SDDT 37.0 35.7 72.0 28.2 37.3 37.6
m (∞) (g) 8.2 8.0 1.5 6.3 4.2 2.1
SDm(∞) 1.7 1.6 0.48 1.1 0.9 0.4
CIm(∞) [5.5 11.4] [5.5 10.6] [0.8 2.4] [4.4 8.1] [2.8 5.6] [1.5 3.0]
Table 5.14. k˘calc, DT , and m (∞) were calculated from parameters estimated from data
simulated assuming the uniform distribution. The standard deviation of the parameters were
found as described in Section 4.5. The confidence interval of m(∞), CIm(∞) was calculated
as described in Section 4.5 assuming a 95% confidence level.
Constants # 12 # 13 # 19 # 21 # 28 # 43
k˘calc (
g2
hr
) 1.65 1.69 0.79 0.62 0.91 0.28
SDk˘calc 0.29 0.29 0.14 0.10 0.15 0.05
DT (Gy) 395 374 918 302 411 458
SDDT 36.0 33.4 85.7 27.3 36.1 42.1
m (∞) (g) 8.8 7.8 1.1 6.8 4.2 2.0
SDm(∞) 1.7 1.5 0.4 1.2 0.8 0.4
CIm(∞) [6.1 12.1] [5.4 10.7] [0.5 1.8] [4.8 8.6 ] [2.8 5.7] [1.3 2.8]
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The parameter estimates and their standard deviations are very similar between Tables
5.13, 5.14, and 5.12. For example, m (∞) =8.2, 8.0, and 1.5 grams for subjects 12, 13, and 19
from Table 5.13. For the same subjects, m (∞) =8.4, 6.1, and 1.7 grams from Table 5.12 and
m (∞) =8.8, 7.8, and 1.1 grams from Table 5.14. The m (∞) values for a particular subject
are within 1.9 grams of each other between the three tables. This provides evidence that
k˘pred and k˘calc provide a reasonable estimate of k˘fit and can be used to accurately calculate
m (∞).
5.4.2 m(∞) Calculated Using Parameters Estimated From The Nonparametric
Bootstrap Simulations
Using the activity and mass parameters estimated from the data simulated assuming the
residuals, DT was calculated as described in Section 4.3. Here, k˘fit was used to calculate DT .
With an estimate of DT , α¯subject was found as described in Section 4.3. Table 5.15 contains
α¯subject and its respective variance for each subject. Using these values, a minimum variance
estimate of α was calculated to be αˆmv=0.0034 Gy
−1 with V (αˆmv)=2.64E-8 Gy−2. Using
Table 5.15. For each subject an average α, α¯subject was calculated along with the variance
in α¯subject as described in Section 4.3.
Constants # 12 # 13 # 19 # 21 # 28 # 43
α¯subject (Gy
−1) 0.0042 0.0040 0.0031 0.0042 0.0033 0.0038
V (α¯subject) (Gy
−2) 1.68E-7 1.75E-7 8.87E-8 2.70E-7 1.70E-7 1.88E-7
αˆmv for all subjects, m (∞) could be calculated as described in Section 4.3. To calculate
m (∞), DT and thus an estimate of k˘ is required. Again, here we used k˘fit to calculate DT
and m (∞). Table 5.16 contains estimates of k˘fit, DT and m (∞).
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Table 5.16. k˘fit, DT , and m (∞) were calculated from parameters estimated from data
simulated using the residuals. The standard deviation of the parameters were found as de-
scribed in Section 4.5. The confidence interval of m(∞), CIm(∞), was calculated as described
in Section 4.5 assuming a 95% confidence level.
Constants # 12 # 13 # 19 # 21 # 28 # 43
k˘fit (
g2
hr
) 2.14 2.58 0.60 1.58 0.77 0.05
SDk˘fit 0.61 0.4391 0.15 0.23 0.21 0.06
DT (Gy) 367 428 619 310 360 376
SDDT 29.2 37.4 43.0 25.6 25.0 26.6
m (∞) (g) 8.7 5.9 2.2 6.9 4.6 2.3
SDm(∞) 1.3 1.0 0.5 1.0 0.6 0.3
CIm(∞) [6.1 11.4] [4.1 8.3] [1.5 3.5] [4.7 9.2] [3.5 6.4] [1.7 3.1]
The statistical distributions of DT and m (∞) were investigated with the use of his-
tograms as described in Section 4.5. Figures 5.14(a) and 5.14(b) are histograms of DT and
m (∞), respectively, for subject 21. By inspection, the histograms appear to follow a normal
distribution.
Table 5.17 reports estimates of k˘pred, DT , and m (∞). Table 5.18 reports estimates of
k˘calc, DT , and m (∞). The parameter estimates and their standard errors are very similar
between Tables 5.17, 5.18, and 5.16. For example, m (∞) = 8.3, 7.6, and 1.9 grams for
subjects 12, 13, and 19 from Table 5.17. For the same subjects, m (∞) = 8.7, 5.9, and 2.2
grams from Table 5.16 and m (∞) = 8.9, 7.5, and 1.3 grams from Table 5.18. The m (∞)
values for a particular subject are within 1.7 grams of each other between the three tables.
This provides evidence that k˘pred and k˘calc provide a reasonable estimate of k˘ and can be
used to accurately calculate m (∞).
83
(a) Histogram of DT for subject 21. (b) Histogram of m (∞) for subject 21.
Figure 5.14. Histograms of the DT and m (∞) for subject 21.
Table 5.17. k˘pred, DT , and m (∞) were calculated from parameters estimated from data
simulated using the residuals. The standard deviation of the parameters were found as de-
scribed in Section 4.5. The confidence interval of m(∞), CIm(∞) was calculated as described
in Section 4.5 assuming a 95% confidence level.
Constants # 12 # 13 # 19 # 21 # 28 # 43
k˘pred (
g2
hr
) 2.50 1.8 0.74 1.19 1.05 0.24
SDk˘pred 0.37 0.25 0.11 0.16 0.14 0.04
DT (Gy) 382 359 660 278 382 438
SDDT 37.0 30.6 55.3 22.5 29.5 34.1
m (∞) (g) 8.3 7.6 1.9 7.7 4.3 1.8
SDm(∞) 1.5 1.2 0.5 1.1 0.7 0.3
CIm(∞) [5.5 11.6] [4.8 10.7] [1.1 3.1] [5.5 10.0] [2.8 6.0] [1.1 2.5]
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Table 5.18. k˘calc, DT , and m (∞) were calculated from parameters estimated from data
simulated using the residuals. The standard deviation of the parameters were found as de-
scribed in Section 4.5. The confidence interval of m(∞), CIm(∞), was calculated as described
in Section 4.5 assuming a 95% confidence level.
Constants # 12 # 13 # 19 # 21 # 28 # 43
k˘calc (
g2
hr
) 1.94 1.82 1.10 0.85 1.04 0.28
SDk˘calc 0.28 0.28 0.14 0.13 0.15 0.04
DT (Gy) 363 363 780 257 386 460
SDDT 33.5 35.4 61.1 20.9 32.8 36.9
m (∞) (g) 8.9 7.5 1.3 8.3 4.3 1.7
SDm(∞) 1.4 1.3 0.3 1.1 0.7 0.3
CIm(∞) [6.2 10.2] [5.0 10.1] [0.61 2.3] [6.0 10.9] [2.8 6.0] [1.2 2.5]
5.5 Standard Propagation Of Error Method Results
The first step in performing the standard propagation of error method was to estimate the
relevant parameter values. Table 5.19 reports the activity parameters and their respective
SE values found using non-linear regression of (5.1) with normalized activity data. Table
5.20 reports the mass parameters and their respective SE values found using non-linear
regression of (5.2) using mass data.
Using the estimated activity and mass parameters, α was found for each subject as
described in Section 3.2.2. Table 5.21 contains α and its respective variance for each subject.
Using these values, a minimum variance estimate of α was calculated to be αˆmv=0.0031 Gy
−1
with V (αˆmv)=1.30E-6 Gy
−2.
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Table 5.19. Activity parameters from (5.1) and their SE estimated using non-linear re-
gression with normalized activity data.
Constants # 12 # 13 # 19 # 21 # 28 # 30 # 43
Yˇ 0.909 0.772 1.232 0.820 0.517 0.988 0.466
SEYˇ 0.035 0.026 0.137 0.006 0.031 0.021 0.014
b (hr−1) 0.0059 0.0055 0.0054 0.0071 0.0059 0.0048 0.0047
SEb 0.0005 0.0003 0.0009 0.0001 0.0007 0.0002 0.0003
c (hr−1) 0.523 0.112 0.082 0.792 0.159 1.271 0.282
SEc 0.076 0.008 0.024 0.021 0.029 0.666 0.041
Table 5.20. The mass parameter k˘fit from (5.2) and its SE estimated using non-linear
regression with mass data.
Constants # 12 # 13 # 19 # 21 # 28 # 30 # 43
k˘fit (
g2
hr
) 1.7 2.4 0.5 1.0 0.5 0.4 0.06
SEk˘fit 5.8E-14 1.8E-15 0.0283 0.0855 0.0857 0.1256 0.0228
Table 5.21. α and its respective variance are reported for each subject. α and its variance
were calculated as described in Section 3.2.2.
Constants # 12 # 13 # 19 # 21 # 28 # 30 # 43
α (Gy−1) 0.0036 0.0037 0.0027 0.0037 0.0032 0.0023 0.0040
V (α) (Gy−2) 1.53E-5 2.90E-5 2.75E-5 3.76E-6 2.46E-5 3.62E-6 1.98E-5
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Using αˆmv for all subjects, m (∞) was calculated. To calculate m (∞), DT and thus an
estimate of k˘ is required. Here we used k˘fit to calculate DT and m (∞). Table 5.22 contains
estimates of k˘fit, DT and m (∞). Each parameters standard error was calculated using the
analytical approximation method.
Table 5.22. Calculated values of k˘fit, DT , and m(∞). Each parameter’s standard error
values were found using the standard propagation of error method.
Constants # 12 # 13 # 19 # 21 # 28 # 30 # 43
k˘fit (
g2
hr
) 1.71 2.41 0.47 1.00 0.50 0.37 0.06
SEk˘fit 5.8E-14 1.8E-15 0.03 0.09 0.09 0.13 0.023
DT (Gy) 427 459 728 347 367 596 379
SEDT 463 668 1413 179 568 490 421
m(∞) (g) 8.2 6.2 2.0 5.9 4.9 2.4 2.7
SEm(∞) 11.4 12.8 9.1 2.3 8.7 3.3 3.4
Table 5.23 reports calculations of k˘pred, DT , and m (∞). Table 5.24 reports calculations
of k˘calc, DT , and m (∞). The parameter estimates and their standard errors are very similar
between Tables 5.23, 5.24, and 5.22. For example, m (∞) = 7.7, 8.0, and 1.8 grams for
subjects 12, 13, and 19 from Table 5.23. For the same subjects, m (∞) = 8.2, 6.2, and 2.0
grams from Table 5.22 and m (∞) = 8.0, 7.8, and 1.6 grams from Table 5.24. The m (∞)
values for a particular subject are within 1.8 grams of each other between the three tables.
This provides evidence that k˘pred and k˘calc provide a reasonable estimate of k˘ and can be
used to accurately calculate m (∞).
The standard errors for DT and m (∞) are unreasonably large and therefore the uncer-
tainties were not calculated. The standard errors calculated from the standard propagation
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Table 5.23. Calculated values of k˘pred, DT , and m(∞). Each parameter’s standard error
values were found using the standard propagation of error method.
Constants # 12 # 13 # 19 # 21 # 28 # 30 # 43
k˘pred (
g2
hr
) 2.00 1.64 0.62 0.84 0.90 0.37 0.24
SEk˘pred 2.25 1.85 1.29 0.39 1.54 0.31 0.32
DT (Gy) 443 380 774 327 407 596 442
SEDT 499 431 1589 158 690 490 557
m(∞) (g) 7.7 8.0 1.8 6.3 4.3 2.4 2.2
SEm(∞) 11.7 10.4 8.8 2.0 9.4 3.4 3.7
Table 5.24. Calculated values of k˘calc, DT , and m(∞). Each parameter’s standard error
values were found using the standard propagation of error method.
Constants # 12 # 13 # 19 # 21 # 28 # 30 # 43
k˘calc (
g2
hr
) 1.80 1.74 0.70 0.62 0.88 0.40 0.28
SEk˘calc 0.33 0.78 0.73 0.09 0.52 0.05 0.08
DT (Gy) 431 387 804 307 404 610 467
SEDT 532 472 1708 160 744 574 683
m(∞) (g) 8.0 7.8 1.6 6.7 4.4 2.3 2.0
SEm(∞) 13.0 11.2 8.6 2.3 10.2 3.9 4.3
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of error method can be compared with the standard deviations calculated from the simulated
data. The estimates of DT and m(∞) are similar between the three methods of estimating
k˘ and therefore only the values calculated using k˘pred will be used to compare the standard
propagation of error and simulation methods. Comparing the parameter estimates from
Table 5.13 with the parameters estimates from Table 5.23 shows that the simulation results
are very different from the standard propagation of error method results. While the param-
eter estimates of k˘pred, DT , and m (∞) are close between the two tables, each parameter’s
standard error is considerably different. The standard errors from the standard propagation
of error method (SEm(∞) = 13.0 grams and 11.2 grams for subjects 12 and 13) are much
larger than the standard deviations from the simulated data (SDm(∞) = 1.4 grams and 1.2
grams for subjects 12 and 13). The standard deviations calculated from the simulated data
are an order of magnitude smaller than the standard errors calculated from the standard
propagation of error method. This implies that the standard propagation of error method
does not provide reasonable estimates of the standard errors and provides evidence that the
simulated data are required for the uncertainty analysis of our new protocol.
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CHAPTER 6
CONCLUSIONS AND FUTURE WORK
In this thesis we presented a new computational protocol for the calculation of RAI in the
treatment of Graves’ hyperthyroidism. The new protocol implemented a two-compartment
model to describe RAI kinetics in the body which allows for the conversion between different
RAI isotopes used in diagnostic and therapeutic applications. The protocol allows for the
prediction of the final thyroid mass from the absorbed dose which is calculated using the
new activity kinetics and an improved method to predict the thyroid mass dynamics directly
related to the activity in the thyroid. Using clinical data consisting of activity kinetics and
mass dynamics of 17 subjects and measured final mass values of 7 of the 17 subjects, we were
able to show that our new protocol can accurately predict the measured final thyroid mass
values. Uncertainty analysis of the protocol was performed using an standard propagation of
error method, however, this yielded large standard error values in the absorbed dose and final
mass. The unreasonable results could be due to the small sample size of the clinical data. As a
result, we simulated additional data using parametric and nonparametric bootstrap methods.
Conclusions could not be made of the statistical distributions of the activity and mass data,
however we were able to obtain a 95 % confidence interval: 0.53m(∞) < m(∞) < 1.38m(∞).
The uncertainty was calculated using the bootstrap methods with a 95% confidence level.
There is an open question, namely, whether this confidence interval is clinically useful,
because, if a subject were at one of the extremes of the confidence interval, it may not
correspond to a euthyroid state.
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There are also some open problems that still remain. One problem would be to identify an
error distribution pertaining to all subjects. The proper way to identify this error distribution
would be through the use of non-linear mixed-effects (NLME) models.
Another problem would be to investigate the quality of the activity parameters estimated
from three activity measurements. We have touched on this briefly in this thesis, however,
a detailed investigation is required. The identification of the activity parameters based on
three measurements is at the heart of our protocol and needs to be formally addressed.
Finally, the constant α in (3.11) needs to be further investigated. Much of the uncertainty
in the final mass estimate is a result from the uncertainty in α. Therefore, if we can find a
better estimate of α, then we can reduce the uncertainty in the calculation of the final mass.
This can be accomplished by either finding a better method of calculating the variance of α,
V (αˆ), or by using the data of more subjects to estimate α.
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APPENDIX A
CLINICAL DATA
Dr. Traino provided us with detailed activity and mass data of 7 Graves’ subjects who
underwent RAI therapy. The data consists of pre-therapy mass m(0) and therapeutic ac-
tivity Ad in Table A.1, measured mass dynamics in Table A.2, and measured, normalized
activity kinetics A(t)
Ad
in Table A.3.
Table A.1. The measured pre-therapeutic mass and the therapeutic activity Ad.
Subject # 12 13 19 21 28 30 43
m(0) (g) 32 27 21 18 16 16 9
Ad (MBq) 666 555 555 370 555 339 296
Table A.2. Measured mass dynamics data.
RAI therapy mass dynamics m(t)
Time (days) # 12 # 13 # 19 # 21 # 28 # 30 # 43
Pre-therapy 32 27 21 18 16 16 9
3 days - - 21 18 17 - 9
7 days - - 18 16 15 - 8
14 days - - 17 9 13 15 8
21 days 23 - 15 11 13 - 9
28 days - - 16 9 13 - 9
30 days - 10 - - - 8 -
35 days - - 16 9 - - 8
1 year 7 5 3 5 5 4 2
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Table A.3. Measured, normalized activity kinetics data.
# 12 # 13 # 19 # 21
Time(hr) A(t)/Ad Time(hr) A(t)/Ad Time(hr) A(t)/Ad Time(hr) A(t)/Ad
0 0 0 0 0 0 0 0
3.3 0.73 6 0.36 2.3 0.06 2 0.64
19.3 0.82 23 0.61 21.5 0.97 22.6 0.70
68.0 0.59 95.0 0.47 45.1 0.88 46.5 0.58
236.2 0.26 263.0 0.18 69.3 0.88 70.5 0.50
404.0 0.05 430.0 0.06 141.4 0.48 140.4 0.30
- - - - 165.1 0.52 163.6 0.26
- - - - 333.2 0.25 332.4 0.07
- - - - 526.5 0.09 500.3 0.02
- - - - 670.3 0.04 - -
# 28 # 30 # 43
Time(hr) A(t)/Ad Time(hr) A(t)/Ad Time(hr) A(t)/Ad
0 0 0 0 0 0
3.5 0.21 3.5 0.96 1.2 0.13
22.6 0.44 22.8 0.87 20.2 0.44
46.3 0.36 70.3 0.73 44.1 0.35
70.0 0.39 239.5 0.30 67.4 0.35
141.7 0.20 407.5 0.14 139.1 0.24
166.0 0.20 - - 163.3 0.23
333.8 0.07 - - 331.2 0.10
501.5 0.03 - - 499.4 0.04
Dr. Traino also provided the normalized activity kinetics data and mass dynamics data
of the additional ten subjects [16]. The initial administered RAI dose and initial measured
mass can be found in Table A.4. The activity kinetics data is in Table A.5 and the mass
dynamics data is in Table A.6.
Table A.4. The measured pre-therapeutic mass and the therapeutic activity Ad.
Subject # 1 2 3 4 5 6 7 8 9 10
m(0) (g) 64 54 43 40 26 18 16 14 13 13
Ad (MBq) 592 666 555 555 629 518 518 518 518 444
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Table A.5. Measured, normalized activity kinetics data.
#1 # 2 #3 # 4
Time(hr) A(t)/Ad Time(hr) A(t)/Ad Time(hr) A(t)/Ad Time(hr) A(t)/Ad
0 0 0 0 0 0 0 0
2 0.52 2 0.10 2 0.49 2 0.35
24 0.46 24 0.44 3 0.44 24 0.52
72 0.32 72 0.39 24 0.34 48 0.62
120 0.26 120 0.31 72 0.38 168 0.38
144 0.23 168 0.26 120 0.26 336 0.13
168 0.19 336 0.12 240 0.13 840 0.02
336 0.1 504 0.05 288 0.11 - -
- - - - 480 0.04 - -
- - - - 576 0.02 - -
# 5 # 6 # 7 # 8
Time(hr) A(t)/Ad Time(hr) A(t)/Ad Time(hr) A(t)/Ad Time(hr) A(t)/Ad
0 0 0 0 0 0 0 0
24 0.43 2 0.34 8 0.20 2 0.17
48 0.46 72 0.47 24 0.41 24 0.38
72 0.41 168 0.24 72 0.28 48 0.29
120 0.38 312 0.10 120 0.23 120 0.21
168 0.30 144 0.21 144 0.21 144 0.21
336 0.11 480 0.047 168 0.16 168 0.21
600 0.03 - - 336 0.07 336 0.08
- - - - 504 0.02 480 0.04
# 9 # 10
Time(hr) A(t)/Ad Time(hr) A(t)/Ad
0 0 0 0
2 0.22 2 0.31
24 0.63 24 0.53
72 0.41 72 0.50
120 0.34 120 0.44
144 0.32 144 0.39
168 0.30 168 0.35
312 0.12 336 0.17
480 0.06 504 0.06
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Table A.6. Measured mass dynamics data.
RAI therapy mass dynamics m(t)
Time (days) # 1 # 2 # 3 # 4 # 5 # 6 # 7 # 8 # 9 # 10
Pre-therapy 64 54 43 40 26 18 16 14 13 13
3 days 56 42 41 39 24 15 15 16 10 -
7 days 58 47 34 36 23 17 16 14 14 12
14 days - 33 33 29 23 7 12 14 10 6
21 days 43 39 32 17 21 - 12 11 12 6
30 days - 25 27 10 20 9 - 7 9 9
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APPENDIX B
CALCULATING THE ACTIVITY PARAMETERS
ANALYTICALLY WITH LIMITED DATA
Before deciding to use non-linear regression to estimate the activity parameters Y , b,
and c with 3 measured data points, we looked into calculating these parameters analytically.
Below is our attempt at finding an analytical solution to this problem.
Original Question. Given a function of the form
A(t) = Y
(
e−bt − e−ct) ,
where b < c and t ≥ 0, is it possible to determine Y , b, and c on the basis of 3 observations
a times t1 < t2 < t3?
Answer. Let c = b+ δ (δ > 0), so
A(t) = Y
(
e−bt − e−bt−δt)
= Y e−bt
(
1− e−δt) ,
and let
ai = A(ti) = Y e
−bti (1− e−δti) .
Also, denote
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η12 =
a1
a2
= e−b(t1−t2)
1− e−δt1
1− e−δt2 , (B.1)
η13 =
a1
a3
= e−b(t1−t3)
1− e−δt1
1− e−δt3 , (B.2)
∆12 = t1 − t2, (B.3)
and
∆13 = t1 − t3. (B.4)
Equation (B.1) can be re-written using (B.3) to yield
eb∆12 =
1
η12
1− e−δt1
1− e−δt2 , (B.5)
also, (B.2) can be re-written using (B.4) to yield
eb∆13 =
(
eb∆12
)P
, (B.6)
where P = ∆13
∆12
> 1. Combining (B.5) and (B.6) yields
(
1
η12
1− e−δt1
1− e−δt2
)P
= eb∆13
=
1
η13
1− e−δt1
1− e−δt3 ,
which reduces to (
1− e−δt1
1− e−δt2
)P
1− e−δt3
1− e−δt1 =
ηP12
η13
. (B.7)
The parameters η12 and η13 are known from observations, if (B.7) can be solved for δ,
then b can be calculated from (B.5) and Y can be calculated from
a1 = Y e
−bt1 (1− e−δt1) . (B.8)
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Denote the left side of (B.7) by f(δ) where δ is the only unknown parameter in (B.7).
The question is whether there exists a δ > 0 such that
f(δ) =
ηP12
η13
.
Note that
f(0+) = lim
δ↓0
f(δ) =
(
t1
t2
)P
t3
t1
f(∞) = 1.
Let u = e−δt1 , so as δ goes from 0 to ∞, u goes from 1 to 0. Now
e−δt2 =
(
e−δt1
) t2
t1 = u
t2
t1 = uτ21
e−δt3 = u
t3
t1 = uτ31 ,
where τ21 =
t2
t1
, τ31 =
t3
t1
, and τ21, τ31 > 1. This results in
f(δ) =
(
1− u
1− uτ21
)P
1− uτ31
1− u
= h(u).
This can be further explored through an example.
Example. Let P=2, τ21=2, and τ31=3. Using these values in the equation for h(u) yields
h(u) =
(
1− u
1− u2
)2
1− u3
1− u
=
u2 + u+ 1
(1 + u)2
.
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Taking the derivative of this equation with respect to u results in
h′(u) =
u2 − 1
(u+ 1)4
,
where 0 < u < 1. If we denote the numerator of h′(u) to be Θ(u), then Θ(0) = -1 and
Θ(1)=0. Taking the derivative of Θ(u) with respect to u results in
Θ′(u) = 2u.
The term Θ′(u) ≥ 0 for 0 ≤ u ≤ 1 and hence Θ(u) is monotone increasing on 0 ≤ u ≤ 1.
Therefore, Θ(u) ≤ 0 and h′(u) ≤ 0 for 0 ≤ u ≤ 1. It follows that h(u) is a monotone
decreasing function. Thus the values of h(u) all lie between h(0)=1 and h(1)=0.75 and the
values of f(δ) lie between 0.75 and 1. Therefore, (B.7) will have a solution δ if and only if
0.75 ≤ ηP12
η13
≤ 1.
General conditions could probably be found that would guarantee a solution to (B.7),
however, we did not pursue this further. We used non-linear regression to estimate the
activity parameters Y , b, and c throughout this thesis.
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APPENDIX C
INVESTIGATING DT
The absorbed dose can be expressed as
DT = σ
∫ ∞
0
A(x)
m(x)
dx.
As described in Section 3.2, we can only directly calculate the mass dynamics, m(t), during
the first time frame. The first time frame, as described in Section 2.2, is assumed to occur
during the first 30-35 days (720-840 hours) after administration of RAI. Throughout this
thesis we have calculated the mass dynamics, m(t), until t = 840 hours, m(840). As a result,
we only calculated the absorbed dose integral to t = 840 hours. Although we cannot prove
that the first time frame does occur during the first 840 hours after RAI administration, we
can prove that the absorbed dose will be not change significantly when calculated up t =
720 hours or up to t = 1080 hours (45 days). To investigate this conjecture, we can re-write
the absorbed dose integral as
DT = σ
∫ t
0
A(t)
m(t)
dt.
We set the upper limit of the integral to the time variable, t, because we want to evaluate
this integral at various times. The following closed from solution of this integral can be
found
DT =
σ
k
(m(0)−m(t)) , (C.1)
where,
m(t) =
[
2
(
Y k
b
e−b t +
Y k
c
− Y k
c
e−c t − Y k
b
+
m(0)2
2
)] 1
2
.
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We calculated the absorbed dose using (C.1) evaluated at times t= 720, 840, and 1080 hours.
The absorbed dose values can be found in Table C.1. As can be seen from Table C.1, DT
does not change significantly when calculated using these three times. While any of these
time values would result in a reasonable DT , we chose to calculate DT up to t = 840 hours.
Table C.1. DT values calculated using (C.1) evaluated at times t = 720, t = 840, and
t = 1080. DT720 denotes the absorbed dose evaluated up to time t = 720. DT840 denotes the
absorbed dose evaluated up to time t = 840. DT1080 denotes the absorbed dose evaluated up
to time t = 1080.
Constants # 12 # 13 # 19 # 21 # 28 # 30 # 43
DT720 Gy 423 451 719 346 364 585 373
DT840 Gy 427 459 728 347 367 596 379
DT1080 Gy 429 466 735 348 369 605 384
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APPENDIX D
CALCULATING KPRED
The general procedure to calculate kpred is described in Section 3.2.1. kpred can be ex-
pressed using (3.9)
kpredi = φ
m2i (0)
gi
− ϕ,
where
gi = 2Y
(
1
c
e−c 840 − 1
b
e−b 840 − 1
c
+
1
b
)
,
and i denotes the ith subject. As described in Section 3.4, an estimate of k˘pred is desired.
The mass constant k˘pred can be expressed as
k˘predi = φ˘
m2i (0)
gˇi
− ϕ˘, (D.1)
where
gˇi = 2Yˇ
(
1
c
e−c 840 − 1
b
e−b 840 − 1
c
+
1
b
)
.
We will describe the procedure to estimate the constants φ˘ and ϕ˘. We used the data for all
17 subjects to calculate these constants because k˘pred is used to estimate the mass dynamics
during the first time frame for which we had data from all subjects. Using the normalized
activity data, the activity parameters Yˇ , b, and c were estimated using non-linear regression
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of (3.13). With these activity parameters, gˇ was calculated for each subject. These values
were stored together in a vector as
gˇi = [193 222 177 292 228 225 141 163 246 296 283 257 433 224 169 401 190],
where i = [1-10,12,13,19,21,28,30,43]. The activity parameters were also used in (3.15) to
estimate k˘fit for each subject. These values were also stored together in a vector as
k˘fiti = [12 9 5 5 1 1 1 1 0.3 0.4 2 2 0.5 1 1 0.4 0.06],
where i = [1-10,12,13,19,21,28,30,43]. Using the measured initial mass, m(0), values
mi(0) = [64 54 43 40 26 18 16 14 13 13 32 27 21 18 16 16 9],
the term
m2i (0)
gˇi
was calculated. These values were also stored in a vector as
m2i (0)
gˇi
= [21 13 10 5 3 1 2 1 1 1 4 3 1 1 2 1 0.4].
Using linear algebra, (D.1) can be expressed as
k˘predi =
[
m2i (0)
gˇi
1
] [
φ˘ − ϕ˘
]T
, (D.2)
where T denotes transpose. Following the argument in Section 3.2.1, k˘fit can replace k˘pred
in (D.2) which yields
k˘fiti =
[
m2i (0)
gˇi
1
] [
φ˘ − ϕ˘
]T
. (D.3)
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Linear regression on (D.3) yields the estimates of φ˘ = 0.5951 and ϕ˘ = 0.0108. Plugging
these estimates into (D.1) yields
k˘predi = 0.5951
m2i (0)
gˇi
− 0.0108,
which can be used to estimate the mass dynamics during the first time frame.
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APPENDIX E
PARAMETRIC BOOTSTRAPPING RESULTS ASSUMING A
NORMAL DISTRIBUTION
The results presented in this appendix are from the parametric bootstrap simulations
when the normal distribution of the error was assumed. This appendix will present both
activity and mass parameters estimated from the original regression of the measured data
and from the simulated data. The parameters obtained from the simulated data were used to
calculate and investigate the error of m(∞). The results of these calculations are presented
in this appendix.
Normal Distribution Simulation Results
In this section, the measurement error distribution was assumed N(0, ζ
2
9
)(ζ = 0.10) as
described in Section 4.1.2. The activity parameters estimated from the measured activity
data and from the simulated data will be presented. Analysis of both methods will be
presented along with a comparison of both methods. The same will be repeated for the mass
parameters.
Activity Results For The Normal Distribution
The original activity parameters were estimated using non-linear regression with the
normalized measured activity data. The procedure discussed in Section 4.1 was still followed
only a normalized version of (4.3),
ln
(
˜ˇA(ti)
)
= −0.00056 + ln (Yˇ )+ ln (e−bti − e−cti)+ ηAi, (E.1)
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was used for the regression of the normalized measured activity data. µA was replaced
with its expected value in (E.1) for the regression. Table E.1 reports the original activity
parameters and their respective standard errors found using non-linear regression of (E.1)
with normalized measured activity data.
Table E.1. The original activity parameters from (E.1) and their SE estimated using
non-linear regression with normalized measured activity data.
Constants # 12 # 13 # 19 # 21 # 28 # 43
ln
(
Yˇ
)
0.016 -0.193 0.285 -0.171 -0.687 -0.738
SEYˇ 0.008 0.014 0.008 0.006 0.007 0.003
b (hr−1) 0.0071 0.0060 0.0052 0.0075 0.0057 0.0049
SEb 0.00004 0.00005 0.00002 0.00003 0.00003 0.00001
c (hr−1) 0.410 0.104 0.037 0.744 0.165 0.272
SEc 0.011 0.003 0.0004 0.021 0.003 0.002
σ2ηA 0.064 0.004 0.089 0.001 0.009 0.004
The normal error distribution was assumed while estimating the activity parameters from
the measured data and therefore µA and σ
2
ηA
could not be compared to their expected values
in order to gain insight of their distributions as described in Section 4.5.1. However, as de-
scribed in Section 4.5.1, a histogram and normal probability plot of Ai was used instead. The
histogram and normal probability plot for Ai found assuming the normal error distribution
were almost identical to Figure 5.1 and therefore were not included in this thesis.
The activity parameters were also estimated from the simulated activity data sets fol-
lowing the method described in Section 4.1.3. Section 4.5 describes how an average estimate
and standard deviation of each activity parameter can be obtained from the N = 500 sets of
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simulated activity parameters. The simulated data was also normalized by Ad, and therefore
(E.1) was used to again estimate the activity parameters. Table E.2 contains the activity
parameters and their standard deviations (SD) estimated from the simulated data.
The activity parameters estimated from the simulated data were used to check the accu-
racy of the results from the original regression of the measured activity data. The estimated
activity parameter values in Table E.2 were compared to their respective estimated values
from Table E.1. All parameter estimates and standard error values match reasonably well
between the two tables except for σ2ηA . The variance σ
2
ηA
estimated from the measured data
is much larger than its respective value from the simulated data. For example, σ2ηA = 0.00008
and 0.00009 for subjects 12 and 13, estimated from the simulated data. For the same sub-
jects, σ2ηA = 0.064 and 0.004 estimated from the measured data. Because of the discrepancy
between the σ2ηA values, the simulations of the activity data assuming a normal distribution
appear to be required to accurately estimate the parameters.
Table E.2. Activity parameters from (E.1) and their standard deviations estimated from
the simulations which assumed a normal distribution.
Constants # 12 # 13 # 19 # 21 # 28 # 43
ln
(
Yˇ
)
0.033 -0.178 0.302 -0.154 -0.670 -0.721
SDYˇ 0.008 0.010 0.008 0.006 0.006 0.005
b (hr−1) 0.0070 0.0060 0.0052 0.0075 0.0057 0.0049
SDb 0.00003 0.00004 0.00002 0.00002 0.00002 0.00002
c (hr−1) 0.411 0.104 0.037 0.745 0.165 0.271
SDc 0.010 0.002 0.0004 0.018 0.002 0.004
σ2ηA 0.00008 0.00009 0.00009 0.00008 0.00009 0.00009
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The activity parameters estimated from the simulated data can also be used to study
their distributions through the use of histograms and normal probability plots as described
in Section 4.5. Figures E.1(a) - E.1(c) are histograms of ln
(
Yˇ
)
, b and c respectively. By
inspection, the figures appear to possibly follow a normal distribution. Figures E.2(a)-E.2(c)
are normal probability plots for each of the activity parameters estimated from the simulated
data. Figures E.2(a) - E.2(c) are normal probability plots of ln
(
Yˇ
)
, b, and c respectively.
Although the tails of the data depart from linearity, the plots suggest that normality could
be approximately correct. However, a conclusion could not be made from these plots alone.
(a) Histogram of ln
(
Yˇ
)
for subject 21. (b) Histogram of b for subject 21.
(c) Histogram of c for subject 21.
Figure E.1. Histograms of the activity parameters from (E.1) assuming a normal error
distribution for subject 21.
108
(a) Normal probability plot of ln
(
Yˇ
)
for subject
21.
(b) Normal probability plot of b for subject 21.
(c) Normal probability plot of c for subject 21.
Figure E.2. Normal probability plots of the activity parameters from (E.1) assuming a
normal error distribution for subject 21. The crosses represent the data points and the
dotted line is used to help evaluate the linearity of the data.
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Mass Results For The Normal Distribution
The original mass parameters were estimated using the method described in Section 4.1.
Equation (5.4) was used to incorporate the normalized activity parameters. Table E.3 reports
the mass parameters and their respective standard errors found using non-linear regression
of (5.4) with measured mass data.
Table E.3. The original mass parameters from (5.4) and their SE estimated using non-
linear regression with measured mass data.
Constants # 12 # 13 # 19 # 21 # 28 # 43
k˘fit (
g2
hr
) 1.95 2.50 0.48 1.18 0.69 0.04
SEk˘fit - - 0.04 0.07 0.09 0.06
µm 0.039 0.040 0.018 0.165 0.077 -0.014
SEµm - - 0.028 0.087 0.036 0.054
σ2ηm - - 0.0016 0.0164 0.0022 0.0043
The estimated µm and σ
2
ηm values were compared to their respective expected values
calculated assuming both a uniform and normal distribution of mi as described in Section
4.5.1. The estimated µm values from the regression are positive for all subjects with the
exception of subject 43. The estimated µm values could not support either a U(-ζ, ζ) or
N(0, ζ
2
9
) distribution of mi (ζ = 0.15) because both expected µm values (µmU=-0.00378 and
µmN=-0.00125 ) are negative. This can be explained by the fact that the error model is
correct, however there is an upward bias or that the error model is wrong. The estimated
σ2ηm values did not support either distribution. The expected σ
2
ηm values are 0.0076 and
0.0025 for the uniform and normal distribution respectively. While on the same order of
magnitude, definite support for either distribution could not be concluded.
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As with the activity kinetics, a histogram and normal probability plot of mi was used to
investigate the error distribution as described in Section 4.5.1. The histogram and normal
probability plot for mi found assuming the normal error distribution were almost identical
to Figure 5.4 and therefore were not included in this thesis.
The mass parameters were also estimated from the simulated mass data sets following the
method described in Section 4.1.4. Section 4.5 describes how an average estimate and stan-
dard deviation of each mass parameter can be obtained from the N = 500 sets of simulated
mass parameters. However, similar to estimating the parameters from the measured mass
data, (5.4) was used to incorporate the normalized activity parameters and estimate the mass
parameters from the simulated data. Table E.4 contains the estimated mass parameters and
their standard deviations (SD).
The mass parameters estimated from the simulated data were also compared to the mass
parameters estimated from the measured data. The estimated mass parameters in Table E.4
were compared to their respective estimated values from Table E.3. k˘fit matched reasonably
well between the two tables. For example, k˘fit = 0.50
g2
hr
and 1.22
g2
hr
for subjects 19
and 21 respectively. These values were obtained from the simulated data. For the same
subjects, k˘fit = 0.48
g2
hr
and 1.18
g2
hr
estimated from the measured data. With the exception
of subject 19, all of the estimated µm values from the simulated data were negative while
the µm values estimated from the measured data were all positive with the exception of
subject 43. However, the standard errors of µm and k˘fit match well between the two tables.
For example, SEk˘fit = 0.04
g2
hr
and 0.07
g2
hr
and SDk˘fit = 0.03
g2
hr
and 0.04
g2
hr
for subjects
19 and 21. Also, SEµm = 0.028 and 0.087 and SDµm = 0.01 and 0.01 for subjects 19
and 21. σ2ηm is on an order of magnitude smaller when estimated from the simulated data(
σ2ηm = 0.0002 for subject 19
)
than from the measured data
(
σ2ηm = 0.0016for subject 19
)
.
The fact that the parameter values do not match well between the two tables suggests that
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the simulated data are required for estimating the mass parameters while assuming a normal
distribution of mi.
Table E.4. Mass parameters from (5.4) and their standard deviations estimated from the
simulations which assumed a normal distribution.
Constants # 12 # 13 # 19 # 21 # 28 # 43
k˘fit (
g2
hr
) 2.01 2.58 0.50 1.22 0.71 0.05
SEk˘fit 0.13 0.09 0.03 0.04 0.04 0.01
µm -.000012 -.000007 0.000894 -0.001160 -0.000141 -0.000059
SEµm 0.001668 0.000374 0.010387 0.010996 0.009915 0.009533
σ2ηm - - 0.0002 0.0002 0.0002 0.0002
Figures E.3(a) and E.3(b) are histograms of the mass parameters k˘ and µm, respectively,
estimated from the simulated data. By inspection, Figure E.3(b) resembles a normal distri-
bution however Figure E.3(a) resembles a uniform distribution. Another approach to gain
insight into the distributions of these parameters is to investigate the normal probability
plots in Figures E.4(a) and E.4(b). Figures E.4(a) and E.4(b) are normal probability plots
of k˘ and µm respectively. In both plots, the tails of the data deviate from linearity, which
does not imply whether these parameters follow a normal distribution or not.
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(a) Histogram of k˘ for subject 21. (b) Histogram of µm for subject 21.
Figure E.3. Histograms of the mass parameters from (5.4) assuming a normal error distri-
bution for subject 21.
(a) Normal probability plot of k˘ for subject 21. (b) Normal probability plot of µm for subject 21.
Figure E.4. Normal probability plots of the mass parameters from (5.4) assuming a normal
error distribution for subject 21. The crosses represent the data points and the dotted line
is used to help evaluate the linearity of the data.
m(∞) Calculated Using Parameters Estimated From Simulations
Of The Normal Distribution
This section presents the results of the calculation of m(∞) as described in Section 4.3. It
presents the calculation of m(∞) using parameters estimated from the normally distributed
data. m(∞) will be calculated using 3 estimates of the mass parameter k˘: 1) k˘ found using
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non-linear regression of mass data, k˘fit, 2) k˘ calculated using (3.16), k˘pred, and 3) k˘ calculated
using (2.8), k˘calc. The 3 estimates of k˘ are used to investigate the error in our new protocol
when using a predictive equation to calculate k˘.
Using the activity and mass parameters estimated from the data simulated assuming
the N(0, ζ
2
9
) distribution, DT was calculated as described in Section 4.3. Here, k˘fit was
used to calculate DT . With an estimate of DT , α¯subject was found as described in Section
4.3. Table E.5 contains α¯subject and its respective variance for each subject. Using these
values, a minimum variance estimate of α was calculated to be αˆmv=0.0033 Gy
−1 with
V (αˆmv)=8.99E-10 Gy
−2.
Table E.5. For each subject an average α, α¯subject was calculated along with the variance
in α¯subject as described in Section 4.3.
Constants # 12 # 13 # 19 # 21 # 28 # 43
α¯subject (Gy
−1) 0.0038 0.0038 0.0026 0.0035 0.0030 0.0041
V (α¯subject) (Gy
−2) 4.52E-9 5.60E-9 2.95E-9 9.13E-9 6.48E-9 9.13E-9
Using αˆmv for all subjects, m (∞) could be calculated as described in Section 4.3. To
calculate m (∞), DT and thus an estimate of k˘ is required. Again, here we used k˘fit to
calculate DT and m (∞). Table E.6 contains estimates of k˘fit, DT and m (∞). The standard
deviation of the parameters were found as described in Section 4.5. The confidence interval
of m(∞), CIm(∞), was calculated as described in Section 4.5 assuming a 95% confidence
level
The statistical distributions ofDT andm (∞) were investigated with the use of histograms
as described in Section 4.5. The histograms of DT and m (∞) were similar to the histograms
in Figure 5.4.1 and were not included in this thesis.
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Table E.6. k˘fit, DT , and m (∞) were calculated from parameters estimated from data
simulated assuming the normal distribution. The standard deviation of the parameters were
found as described in Section 4.5. The confidence interval of m(∞), CIm(∞), was calculated
as described in Section 4.5 assuming a 95% confidence level.
Constants # 12 # 13 # 19 # 21 # 28 # 43
k˘fit (
g2
hr
) 2.01 2.58 0.50 1.22 0.71 0.04
SDk˘fit 0.13 0.08 0.03 0.04 0.04 0.01
DT (Gy) 400 448 758 367 384 366
SDDT 4.25 5.59 9.58 4.74 4.53 4.24
m (∞) (g) 8.7 6.3 1.7 5.5 4.6 2.7
SDm(∞) 0.2 0.2 0.1 0.2 0.1 0.1
CIm(∞) [8.3 9.1] [6.0 6.6] [1.6 1.9] [5.2 5.8] [4.4 4.8] [2.6 2.9]
Table E.7 reports estimates of k˘pred, DT , and m (∞) which were calculated from param-
eters that were estimated from data that was simulated assuming a normal distribution.
Table E.8 reports estimates of k˘calc, DT , and m (∞). The parameter estimates and their
standard errors are very similar between Tables E.7, E.8, and E.6. For example, m (∞)
=8.4, 8.2, and 1.5 grams for subjects 12, 13, and 19 from Table E.7. For the same subjects,
m (∞) =8.7, 6.3, and 1.7 grams from Table E.6 and m (∞) =9.1, 8.2, and 1.1 grams from
Table E.8. The m (∞) values for a particular subject are within 1.9 grams of each other
between the three tables. This provides evidence that k˘pred and k˘calc provide a reasonable
estimate of k˘fit and produce similar estimates of m (∞). However, the confidence intervals
are unrealistically narrow.
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Table E.7. k˘pred, DT , and m (∞) were calculated from parameters estimated from data
simulated assuming the normal distribution. The standard deviation of the parameters were
found as described in Section 4.5. The confidence interval of m(∞), CIm(∞), was calculated
as described in Section 4.5 assuming a 95% confidence level.
Constants # 12 # 13 # 19 # 21 # 28 # 43
k˘pred (
g2
hr
) 2.22 1.74 0.62 0.88 0.92 0.25
SD ˘kpred 0.06 0.05 0.02 0.02 0.03 0.01
DT (Gy) 410 368 795 320 407 430
SDDT 6.10 5.71 11.38 4.44 5.89 5.92
m (∞) (g) 8.4 8.2 1.5 6.4 4.3 2.2
SDm(∞) 0.3 0.3 0.1 0.2 0.1 0.1
CIm(∞) [8.0 8.9] [7.7 8.6] [1.4 1.7] [6.1 6.7] [4.0 4.5] [2.1 2.3]
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Table E.8. k˘calc, DT , and m (∞) were calculated from parameters estimated from data
simulated assuming the normal distribution. The standard deviation of the parameters were
found as described in Section 4.5. The confidence interval of m(∞), CIm(∞), was calculated
as described in Section 4.5 assuming a 95% confidence level.
Constants # 12 # 13 # 19 # 21 # 28 # 43
k˘calc (
g2
hr
) 1.71 1.73 0.83 0.63 0.92 0.29
SDk˘calc 0.05 0.05 0.02 0.02 0.03 0.01
DT (Gy) 387 368 893 298 407 447
SDDT 5.70 5.48 13.15 4.30 6.15 6.40
m (∞) (g) 9.1 8.2 1.1 6.9 4.3 2.1
SDm(∞) 0.3 0.3 0.1 0.2 0.1 0.1
CIm(∞) [8.6 9.6] [7.8 8.6] [1.0 1.2] [6.6 7.2] [4.0 4.5] [2.0 2.2]
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